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Abstract (Hookah)
Cardiovascular diseases (CVD’s) is a major public health problem. Among CVD’s risk factors,
tobacco smoking is considered the single most preventable cause of death, with thrombosis being
the main mechanism of CVD’s mortality in smokers. While tobacco smoking has been on the
decline, the use of waterpipe/hookah has been rising, mainly due to the perception that they are
“less harmful” than regular cigarettes. Strikingly, there are few studies on the negative effects of
waterpipes on the cardiovascular system, and none regarding their direct contribution to thrombus
formation. We employed a waterpipe whole-body exposure protocol that mimics real‐life human
exposure scenarios, and investigated its effects, relative to clean air, on platelet function,
hemostasis and thrombogenesis. We found that both adults as well as in utero waterpipe smoke
(WPS) exposed mice exhibited shortened thrombus occlusion and bleeding times. Further, our
results show that platelets from adults and in utero WPS exposed mice are hyperactive, with
enhanced agonist-induced aggregation, dense and α-granule secretion, αIIbβ3 (GPIIb/IIIa) integrin
activation, phosphatidylserine expression and platelet spreading, when compared with clean airexposed platelets. Finally, at the molecular level, it was found that Akt and ERK phosphorylation
are enhanced in the adult WPS exposed-, and in nicotine-treated platelets. Our findings
demonstrate, for the first time, that adult and in utero WPS exposure directly modulate hemostasis
and increases the risk of thrombosis, and that this is mediated, in part, via a state of platelet
hyperactivity. The negative health impact of WPS/hookah, therefore, should not be
underestimated. Moreover, this study should also help in raising public awareness of the toxic
effects of waterpipe/hookah.
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Abstract (G subunits)

Platelet activation involves tightly regulated processes to ensure a proper hemostasis response, but
when unbalanced, it can lead to pathological consequences such as thrombus formation. G-protein
coupled receptors (GPCRs) regulate platelet function by mediating the response to various
physiological agonists. To this end, an essential mediator of GPCR signaling is the G protein Gα
heterotrimers, and the βγ subunits are central players in downstream signaling pathways. While
much is known regarding the role of the Gα subunit in platelet function, that of the  remains
poorly understood. Therefore, we investigated the role of G subunits in platelet function using
a G (small molecule) inhibitor, namely gallein. We observed that gallein inhibits platelet
aggregation and secretion in response to agonist stimulation, in both mouse and human platelets.
Furthermore, gallein also exerted inhibitory effects on integrin αIIbβ3 activation and clot
retraction. Finally, gallein’s inhibitory effects manifested in vivo, as documented by its ability to
impair physiological hemostasis and delay thrombus formation. Taken together, our findings
demonstrate, for the first time, that G directly regulates GPCR-dependent platelet function, in
vitro and in vivo. Moreover, these data highlight G as a novel therapeutic target for managing
thrombotic disorders.
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Chapter I: Introduction
Cardiovascular Diseases
According to the world health organization (WHO), cardiovascular diseases (CVDs)
are the leading cause of death globally, taking an estimated 17.9 million lives each year. Generally,
CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease,
cerebrovascular disease, rheumatic heart disease, and other heart conditions. In the united states
(US) CVDs remain the leading cause of death with a death toll of 840,768 deaths (635,260 cardiac)
in 2016 (Benjamin et al. 2019). In addition, CVDs are tied to a huge economic burden with a yearly
total cost of $351.2 billion in 2014-2015, with $213.8 billion in direct cost, including 46% for
inpatient care. These numbers make CVDs of huge public health concern and an issue that need
continuous attention. Among CVDs, coronary heart disease (CHD) constitutes (43.2%) and is the
leading cause of death from CVDs followed by stroke with (16.9%) (Benjamin et al. 2019). Both
CHD and stroke are thrombotic based cardiovascular diseases in which the process of thrombosis
plays a major role in their pathogenesis (Raskob et al. 2014). It is well established that platelets
play a major role in the process of thrombosis, and antiplatelet drugs have long been shown to be
beneficial for treatment and prevention of acute coronary events. Therefore, understanding
platelets and their function have become very important. We will discuss platelets and their
function in the next section.
Platelets (Origin, Morphology, and Function)
Platelets are small (1-3μm) desk shaped cells that originate from the megakaryocyte cells
in the bone marrow (Patel, Hartwig, and Italiano 2005). These small cells have a short life span of
7-10 days and the majority (2/3) of platelets are stored in the spleen. Platelets serve a very essential
function which is hemostasis (the ability of the vascular system to maintain its own integrity and
1

stop blood loss). During normal condition, platelets circulate in a resting state, however, when
triggered by vascular injury, platelets are rapidly activated and aggregate to form a primary
hemostatic plug (platelet plug) on the vessel wall, which along with coagulation cascade help seal
the vascular leakage, and as consequence prevent blood loss (Gremmel, Frelinger, and Michelson
2016). Hemostasis is a well regulated process in which any disruption to this process can lead to
an unwanted extension of the platelet plug, which results in a pathological thrombosis (Packham
1994) (occlusion of blood flow to vital organs/tissues by the pathological thrombi). Occlusion of
blood flow to an organ can lead to oxygen deprivation (hypoxia), in which if it’s long enough can
consequently lead to tissue death.
Primary Hemostatic Plug (Platelet Plug)
Normal endothelium of blood vessels helps keep platelets in resting state by releasing
different substances that inhibit platelet activity, and that maintains blood in a fluid state (Yau,
Teoh, and Verma 2015). When a break/damage happens to the endothelium, the subendothelial
matrix will be exposed and therefore platelets start to gravitate toward the exposed matrix (e.g.,
collagen) and adhere to it in a process called adhesion. Consequently, platelets get activated and
that leads to secretion of substances stored inside their granules to the outside local environment
to help in recruiting other platelets to clump together in a process called aggregation, and this will
lead to the formation of the primary hemostatic plug (platelet plug). At this stage, the primary
hemostatic plug is unstable and therefore, the secondary hemostatic plug takes place through the
coagulation cascade to transform the soluble fibrinogen to insoluble fibrin. This insoluble fibrin
forms a network mesh around the platelet plug, which serves to strengthen and stabilize the blood
clot. Both the primary hemostatic plug (platelet plug) and the coagulation cascade processes
happen simultaneously and are mechanistically intertwined (Gale 2011).
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Platelet Signaling (Agonists and Receptors)
On the cellular level, the ability of platelets to adhere to the exposed subendothelial matrix
and to aggregate is mediated by a number of receptors, agonists, adhesive proteins and plasmaderived adhesive proteins. One of the most important receptors in the process of adhesion is GPIbIX-V receptor which binds to von Willebrand factor (vWF), an important step for the adhesion
with the subendothelial collagen matrix under the sheer flow. GPVI is another receptor that is
activated by collagen and is important for platelet adhesion and subsequent activation (Gale 2011).
Platelet integrin activation is mandatory for the process of aggregation. In particular
αIIbβ3, α2β1 and αvβ3, which are normally present on the platelet surface in an inactive form, but
platelet activation induces conformational changes and that exposes ligand binding sites (Luo and
Springer 2006, Xiao et al. 2004). Of all the integrins in platelets, αIIbβ3 is the most important of
these receptors as it is present in abundance on the platelet surface. In addition, αIIbβ3 binds to
multiple ligands that promote platelet-platelet aggregation including fibrinogen, VWF, collagen,
fibronectin and vitronectin (Varga-Szabo, Pleines, and Nieswandt 2008).
Feedback activation of the locally available platelets surrounding the site of injury is
critical for further aggregation and propagation of the platelet plug. This activation is mainly
mediated by agonists released by activated platelets themselves acting on G protein-coupled
receptors (GPCRs). Of those, adenosine diphosphate (ADP) is released from platelet dense
granules and binds to its receptors, namely P2Y1 and P2Y12 (Mills 1996). Thromboxane A2 is
synthesized de novo by activated platelets and binds to the thromboxane receptor (TPR) on
platelets (Hanasaki and Arita 1988). Furthermore, serotonin is also secreted from dense granules
and contributes to platelet activation through 5HT2A receptors. The collective results of the
organized work of this network of receptors and agonists are the formation of the primary
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hemostatic plug. One important step in platelet activation that is linked to the formation of the
secondary platelets plug is the formation of thrombin. Thrombin is the terminal serine protease
product of the coagulation cascade. Thrombin cleaves 2 protease-activated receptors (PARs) on
human platelets, PAR1 and PAR4. These are also G protein-coupled receptors (GPCRs), and
cleavage by thrombin exposes a new N-terminus that serves as a tethered ligand to activate the
receptor (Kahn et al. 1998, Vu et al. 1991). All of these receptors transduce signaling which
ultimately results in platelet granule secretion, integrin activation and platelet cytoskeleton
changes that are needed for full platelet function. Once platelet GPCRs are activated by their own
agonists, they initiate various intracellular signaling pathways that include activation of
phospholipase C (PLC), protein kinase C (PKC), and phosphoinositide (PI)-3 kinase. Both calcium
and PKC contribute to activation of the small G protein, Rap1b, which, through interactions with
the Rap1-GTP interacting adapter molecule (RIAM) and talin, are important for binding of
fibrinogen and other ligands to integrin GPIIb/IIIa (αIIbβ), an essential facilitator of platelet
aggregation (Smyth et al. 2009).
Platelets and Environmental Effects
There is an accumulating body of evidence highlighting a relationship between external
environmental effects and diseases including cardiovascular diseases such as myocardial infarction
(Peters et al. 2004). Environmental effects can include behavioral factors, lipid and sodium content
of the diet, workload, and pollutant exposure, and more importantly smoking/tobacco use
(Hammerschmidt 1982). One important mechanism that has been identified involves increased
susceptibility to the formation of thrombi (increased risk of thrombosis due to hyperactive
platelets) in diseased arteries, which ultimately leads to disease conditions such as myocardial
infarction and stroke. It is noteworthy that the initiating events in thrombosis formation
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imperatively involve platelet adherence, activation, and aggregation. To this end, thrombosis is
one of the main mechanisms of smoke-induced cardiovascular events, and while cigarette smoking
has been declining, usage of other forms of tobacco, including hookah, has been on the rise
(Jukema, Bagnasco, and Jukema 2014a) .
Platelets as a Target for Therapy
The cardinal role played by platelets in the process of thrombosis provides a strong
rationale for blocking their function in thrombotic disease states such as in coronary heart disease
(CHD). Following adhesion at the site of exposed subendothelial matrix in the presence of shear
force, platelets get activated and release their granule contents such as ADP (dense granules) and
generate arachidonic acid from membrane phospholipids via the cyclooxygenase-1 (COX1)/thromboxane synthase pathway and thrombin through the coagulation pathway on the surface
of activated platelets. ADP, thromboxane A2, and thrombin act on their G-protein-coupled
receptors: P2Y1 & P2Y12, TPR, as well as PAR1 and PAR4, respectively, and a cascade of
intracellular signaling events culminate in the activation of the GPIIb/IIIa (aka αIIbβ3) receptor
that then binds to fibrinogen to mediate platelet aggregation. Studies showed that the contributions
of these upstream receptors to thrombosis is very important. Therefore, targeting these receptors
(COX1 inhibitors, P2Y12 receptors blockers, and PAR1 receptors blockers) is one of the most
current effective means to inhibit platelet function and to combat cardiovascular (CV) events in
high-risk patients. Nonetheless, these current antiplatelet agents come with caveats, that is, many
of these therapies are associated with dangerous side effects such as bleeding. Furthermore, some
of these treatments are associated with a high rate of resistance as well as failure (Cedillo-Salazar
et al. 2019, Paven et al. 2019). To this end, there is an urgent need for more specific targets to
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inhibit platelet function and at the same time avoid the major side effects that are associated with
the current available antiplatelet agents.
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Chapter II: The Effect of Waterpipe/Hookah on Platelet Function

Introduction
Hookah also known as waterpipe, narghile, argileh, shisha, hubble-bubble, goza, borry,
qaylan, chica and mada’a (Figure 1.1) is a tobacco pipe with a long yet flexible tube that draws the
smoke through water contained in a bowl (Bou Fakhreddine, Kanj, and Kanj 2014). Even though
hookah use in the western world is a recent trend, it has existed for a millennium; emerging in the
North-Western provinces of India, spreading to Iran, the Arab world, Turkey and now gaining
popularity in the US and Europe (Jukema, Bagnasco, and Jukema 2014a).

Figure 1.1: PubMed search results for the different names of hookah used in the
literatures. Hookah is the most common used term followed by water-pipe and shisha.

Apparatus Description
The hookah or hookah apparatus is composed of an upper and lower compartment
connected by a pipe (Figure 1.2). Briefly, the top consists of a bowl where tobacco or molasses are
placed then covered with perforated aluminum foil above which burning charcoal is placed. On
the bottom of the apparatus resides a water jar covered by a gasket, protruding a hose and a release
valve (used for clearing out stagnate smoke) (Bou Fakhreddine, Kanj, and Kanj 2014, Jukema,
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Bagnasco, and Jukema 2014a, Nakkash and Khalil 2010a). A detailed description of hookah
components is provided in Table 1.1: Hookah apparatus components and their use.

Figure 1.2: A typical hookah apparatus.

Table 1.1: Hookah apparatus components and their use.
Component

Usage/ properties

Apparatus (Chaouachi 2011, Bou Fakhreddine, Kanj, and Kanj 2014, Jukema, Bagnasco,
and Jukema 2014a, Nakkash and Khalil 2010a)
Water Jar (base)

Glass container that is filled with water, however, other liquids might be
used (milk, fruit juices or even alcohol)

Pipe (body, stem) A metallic tube extending from the bowl to the base (partially immersed in
water)
Bowl (head)

Carries (10-20g) of tobacco

Saucer

Holds charcoal ashes

Accessories (Nakkash and Khalil 2010a)
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Filter

A device that can be placed on the tip of the hose, marketed with claims
that it reduces exposure to nicotine and tar.

Mouthpiece

A short plastic tip fitted into the hose as an extension to it.

(extension)
Aluminum foil

Used as a membrane between tobacco (beneath it) and the charcoal (above
it).

Consumables (Nakkash and Khalil 2010a, Chaouachi 2011)
Charcoal

A special type of charcoal round pellets that are easily lit (Nakkash and
Khalil 2010b) (made from wood, coconut shell or other material).

Tobacco

Marketed in two forms (moassel: fruit-flavored tobacco, pliable and moist)
and (ajami: unflavored tobacco).
(Steam stones: heat-treated materials soaked with glycerin) are new
“healthy” tobacco alternatives are released. (Lee, Mukherjea, and Grana
2013)

Even though hookah retains some of its features globally (presence of liquid through which
smoke passes), there is immense variability in the consumables, sizes, and materials used to
manufacture apparatus parts; due to personal preferences and cultural/regional differences
(Chaouachi 2011, Regulation. 2015). It is noteworthy that manufacturing material variability may
influence the levels of smoke/chemicals exposure. Indeed one study reported that differences in
pipe material affected the levels of carbon monoxide(CO) exposure, correlating the non-porous
plastic hose with higher yields of CO compared to the more porous leather hose (Saleh and
Shihadeh 2008). The same theory could apply to yields of other chemicals, especially nicotine.
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Hence, hookah effects may be under/overestimated in some studies, so future research should take
into consideration such variations to make results more relevant.
Hookah Tobacco
There are three commonly used types of hookah tobacco, Mouassal, Jurak, and Tumbak,
each contains different ingredients. In brief, Mouassal which is an Arabic translation for “honeyed”
contains 30% tobacco, and around 70% honey/sugarcane as well as glycerol and flavors(Khater et
al. 2008). Hadidi et al (2004) estimated that the nicotine content of Mouassal is about 3.4mg/g.
Jurak on the other hand, contains tobacco, sugarcane, and around 20% other spices and dried fruits
(Hadidi and Mohammed 2004). Jurak is commonly used in the Middle East and Gulf region.
Finally, Tumbak, which is used mainly in Asia, is a pure form of unflavored tobacco leaves
(Ajami) smoked with charcoal.
Hookah Tobacco Flavors
In the US, there are different flavors used in hookah tobacco with the most popular being
the fruit flavors (Smith-Simone et al. 2008). Similarly, among university students, fruit-flavored
tobacco was preferred to unflavored ones (Salloum, Maziak, et al. 2015). Among US women,
candy/sweet and menthol are the second and third preferred flavors respectively, with fruit flavors
still number one choice (Scott-Sheldon and Stroud 2018). Other flavors include chocolate,
clove/spice, alcohol, and other beverages (Smith-Simone et al. 2008). This suggests that flavored
tobacco plays a major role as a “motivator” for using a hookah, which provides the user with
pleasant taste and smell.
Hookah Preparation and Mechanism of Operation
The user or the person preparing the hookah (Figure 1.2) starts by loading the tobacco into
the bowl before wrapping the head with aluminum foil and then perforating the foil by using a
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screen pincher or toothpick. After that, the “ignited” charcoal is placed on the top perforated foil
to initiate the tobacco heating process (Kim et al. 2016). During inhalation, charcoal heated air
passes through the pierced aluminum foil and through the tobacco down the pipe and towards the
water. After “bubbling” through the water, the cooled smoke reaches the surface and is drawn
through the hose and is inhaled (Gatrad, Gatrad, and Sheikh 2007, Nakkash and Khalil 2010a).
Taken together, hookah smoking seems to have a complex puffing behavior when compared to
conventional cigarette smoking.
Puffing Topography
Both cigarette and hookah-smoking topography serve as an indirect measure of smoke and
chemical exposure (Kim et al. 2016, Lee et al. 2003). In comparison to cigarettes, hookah-puffing
is more variable including total puffing time, number of puffs, and total smoke inhaled, all being
affected by nicotine content of tobacco, presence of flavors, personal preferences and the social
setting of the vaping session (Blank et al. 2011, Kim et al. 2016, Cobb et al. 2015). Regarding total
puffing time, hookah use takes significantly longer periods (30-90 minutes/session) (Kadhum et
al. 2014, Cobb et al. 2012, Shihadeh 2003a, Maziak et al. 2004, Kim et al. 2016) in comparison to
cigarette smoking (averages 5-6 minutes) (Djordjevic, Stellman, and Zang 2000, Kim et al. 2016).
Furthermore, the number of puffs, mean puff duration, puff volume and inter-puff intervals were
higher in hookah (Blank et al. 2014, Eissenberg and Shihadeh 2009, Anand et al. 2013), in contrast
to conventional smoking (Krebs et al. 2016, Matsumoto et al. 2013). The longer sessions of hookah
smoking could explain the increase in number of puffs/sessions. Also, the “humid” nature of the
hookah smoke makes it more pleasant than the dry cigarette smoke and facilitates higher volume
uptake (Cobb et al. 2015, Shihadeh and Saleh 2005, Blank et al. 2011). Importantly, this higher
humidity of the smoke and its cooled-down nature facilitates deeper inhalation potentially
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increasing the side effects of using hookah (Jukema, Bagnasco, and Jukema 2014a). Given the
behavioral complexity of hookah use/smoking, further examination of smoking patterns is
warranted in order to accurately estimate users’ exposure to harmful chemicals.
Reasons and Prevalence of Hookah Use
As mentioned before, hookah became widely popular, with its use accelerating rapidly
especially among youth and women (Palamar et al. 2014, Shearston et al. 2016). Thus,
understanding the reasons/ patterns of use will aid in developing strategies to better control hookah
use. Although there are ample justifications in the literature for hookah use, in this section we will
include the most commonly reported, in addition to the prevalence of hookah.
Reasons for Use
Many factors seem to have promoted hookahs’ spread/use, including but are not limited to
perception of “no/less harm” of hookah, social acceptance/less restrictions, accessibility, use of
flavored aromatic tobacco, curiosity, peer pressure, fashion, higher socioeconomic status and need
for amusement (Amin et al. 2012, Martinasek, McDermott, and Martini 2011, Kelishadi et al.
2007, Baheiraei et al. 2015, Wong et al. 2016, Palamar et al. 2014, Ward et al. 2007, Giuliani et
al. 2008). One factor that drastically contributed to the increased hookah use (similarly to ecigarette use) is the misperception about the health risks. Majority of users believe in the “no or
less harm” of hookah compared to cigarettes; this particular belief could be connected with the
myths of intermittent use of hookah that reduces harm compared to constant use of cigarettes
(Maziak, Eissenberg, and Ward 2005), the passage of smoke through water would filter it, and
“the less” addictive nature of hookah (Jukema, Bagnasco, and Jukema 2014a). Some users argue
that they do not inhale the smoke (keep it in the mouth cavity), therefore protecting themselves
from nicotine absorption/addictive effects. However, nicotine could be easily absorbed through
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the mucosal lining of the oral cavity (Jukema, Bagnasco, and Jukema 2014a). Furthermore,
receiving the “positive” attributes of hookah such as socializing, relaxing and the good taste/smell
of the smoke seems to encourage and maintain hookah use (Smith-Simone et al. 2008, Primack et
al. 2008). To this end, a recent study conducted on social media (Twitter) found that social events
and flavors were among the common contexts and experiences associated with Twitter discussions
about hookah (2017-2018) (Allem et al. 2018). Finally, one study demonstrated that participants
preferred flavored hookah because the “sweet” flavored smoke smell is not viewed as offensive as
cigarette smoke (Giuliani et al. 2008), which supports the conclusion that flavor plays an important
role in promoting hookah use. Thus clearly, there should be more emphasis on research studies
that examine hookah health risks, which would inform campaigns for educating the public on the
myths and the negative health effects associated with hookah use.
Prevalence
Worldwide, it is estimated that 100 million people use hookah on a daily bases (Ward et
al. 2005). Back in 2011 “current hookah use” among adults age >18 years was 15% in Lebanon,
9-12% in Syria 4-12% in Arabic gulf countries
and 6% in Pakistan (Akl et al. 2011), and 30% in
Jordan (Khabour, Alzoubi, Eissenberg, et al.
2012) whereas in Iran it was found that more
nonsmokers transition to tobacco use including
waterpipe/hookah

(Khosravi

et

al.

2018).

Comparable to those levels, US adults “current
use- smoking waterpipe on at least 1 day within the

Figure 1.3: Distribution of hookah “ever use” in
the United States. From the National Adult
Tobacco Survey (NATS) 2012-2013 (n = 60192)
(Park et al. 2017a).

past 30 days” was 9.8% and “ever use- smoking waterpipe at any point in lifetime” was 1.5%

13

between 2009-2010 (Salloum, Thrasher, et al. 2015) reaching levels of 12.3% and 3.3%
respectively by 2012-2013, reflecting a gross increase within the US population (Park et al. 2017b).
Furthermore, while the majority of US hookah users are also tobacco smokers, a significant portion
of hookah users are non-smokers (Ward et al. 2007, Primack et al. 2008). In this connection,
differences between rural and urban US in smoking hookah was also examined, and the results
illustrated more prevalence of hookah use in urban areas in comparison to rural areas (Roberts et
al. 2017). This difference could be attributed to the sociocultural and economic factors linked to
living in urban areas. Besides that, the distribution among the states/regions was found to be
variable (Park et al. 2017a) (Figure 1.3), with west states having higher prevalence compared to
south states; in particular, five states, namely Arizona, California, Colorado, the District of
Columbia and Nevada had high rates of both current hookah use ( ≥ 5%) and ever use (≥ 15%)(Park
et al. 2017b).
It is difficult to determine what might be the cause behind this increase in the west, but
potentially it might derive-in part- from the higher population of Arab Americans within these
regions. This notion is supported by Arab Americans have the highest rates among all racial/ethnic
groups of adults identifying themselves as non-Hispanic “Other”(Salloum, Thrasher, et al. 2015).
Regardless, conducting research on hookah environment characteristics such as the number of
hookah bars, methods of advertising, and social behaviors could serve as the first step in further
understanding the increasing prevalence and popularity of hookah.
Hookah use among the US youth population in schools was under scrutiny in many studies.
For instance, one study surveyed a representative sample of students 6th- 12th grade for hookah use,
and the results showed that 10.5% reported smoking hookah (Agaku et al. 2018). Another study
documented that hookah “ever use” among middle and high school students in the US included
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6.8-15% of the students (Martinasek, McDermott, and Martini 2011). These results are remarkable
as they show that as young as sixth grade (vulnerable population) can be a user of hookah, and
potentially exposed to all associated health risks. According to the same study, household hookah
users and easy access are of the main motivation factors to use hookah in such a young age (Agaku
et al. 2018). Interestingly, Arab Americans had a higher percentage of both “current and ever use”
compared to non-Arabs, which indicates a strong influence of cultural background on hookah use
(Weglicki et al. 2008).
College students’ prevalence of hookah use was 9.6% for “current use” and 22.9% for
“ever use” between 2008-2009, whereas it increased to 28.4% for “past year” use and 46.4% for
“ever use” in 2013 (Barnett et al. 2013). Such an alarming increase may be in part due to the belief
that hookah use is less harmful/addictive with higher social approval in comparison to tobacco
(Heinz et al. 2013, Noonan and Patrick 2013). Notably, this belief is the major reason many adults
use hookah, in addition viewing it as a good way of socializing, and the belief that it helps quitting
cigarettes, as well as being relatively cheaper than smoking cigarettes (Wong et al. 2016). Another
drastic and more concerning increase of 5.3% from 2011 to 2014 in hookah popularity was
reported among adolescents in US. This is especially troublesome as adolescents continue to be
exposed to harmful tobacco product constituents, in particular, nicotine that might interfere with
brain development, cause addiction, and might lead to sustained future tobacco use (Arrazola et
al. 2015). Another recent representative sample of young adults aged 15-24 years old, revealed
that hookah use was 14.7% among males and 10.2% among females (Li et al. 2018). This increase
in use could be attributed to the perception of fewer negative consequences of hookah smoking
compared with cigarette smoking and the social norms regarding its acceptability among this
population (Holtzman, Babinski, and Merlo 2013, Montgomery et al. 2015, Berg et al. 2015).
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Importantly, developing new perhaps “more rigid” policies to regulate hookah use, is not
only needed in youth but must also expand to control use during pregnancy. This is rather a public
health priority given hookah’s prevalence (12.4%) (Kurti et al. 2017), coupled with the relatively
“high” passive exposure to hookah smoke (32.8%) during gestation (Azab et al. 2013); which in
turn leads to the involuntary exposure of innocent fetuses to hookah, and subjecting them to
hookah’s potential harmful effects (Kahr et al. 2015).
Regardless of the variability in hookah prevalence amongst the various populations,
clearly, there is an overall drastic increase in its use over a short period. Longitudinal studies should
further help in understanding and evaluating use trends, sociodemographic characteristics, health
risks in various populations being exposed to/using hookah, which would ultimately shape new
“more strict” policies, especially those governing the use of highly vulnerable populations,
including pregnant females, and youth.
Toxicological Profile
Even though hookah has been present for a millennium, far less studies have examined its
chemical Constituents/air quality relative to cigarettes. With tobacco being the main source of
smoke in both hookah and cigarettes, hookah users are exposed to many of the same toxic
compounds/by products as cigarette users but at dramatically higher levels, which might, in fact,
produce worsened health effects in users (Eissenberg and Shihadeh 2009). Consequently, it is
important to evaluate the major compounds expelled from hookah vape, in order to aid in
evaluating both acute and chronic health outcomes.
Several toxicants have been found in mainstream hookah smoke including nicotine
(Shihadeh and Saleh 2005, Schubert et al. 2011, Shihadeh 2003b, Jacob et al. 2011, Shihadeh et
al. 2012), carbon monoxide (Jacob et al. 2011, Shihadeh and Saleh 2005), carcinogenic polycyclic
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aromatic hydrocarbons (PAHs) (Shihadeh and Saleh 2005, Jacob et al. 2011, Schubert et al. 2011,
Sepetdjian, Shihadeh, and Saliba 2008b, Shihadeh et al. 2012), aromatic amines (Jacob et al. 2011),
aldehydes (Shihadeh et al. 2012, Al Rashidi, Shihadeh, and Saliba 2008), furanic and phenolic
compounds (Sepetdjian et al. 2013, Schubert et al. 2012), tar (Schubert et al. 2011, Shihadeh
2003a), particulate matter (Monn et al. 2007) heavy metals (Shihadeh 2003a) and ammonia (Baker
and Dixon 2006). It is noteworthy that the amounts of these toxicants might be higher/lower in
hookah compared with cigarette smoke (per cigarette/ and per pack/day) due to different heating
processes and charcoal combustion (Chaouachi 2009, Shihadeh et al. 2014, Calafat et al. 2004,
Moldoveanu, Coleman, and Wilkins 2008) (Figure 1.4).
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Figure 1.4: Comparison of the levels of some toxicants expelled in both hookah and tobacco smoke. (A)
Levels of the toxicants tar, CO. (B) carbonyl compounds (formaldehyde and acetaldehyde), and (C) certain PAHs
are indicated. Levels of toxicants in pack/day are extrapolated by multiplying the levels in one cigarette by 20
(Chaouachi 2009, Shihadeh et al. 2014, Calafat et al. 2004, Moldoveanu, Coleman, and Wilkins 2008).

Nicotine- the major source of tobacco addiction- content in hookah is extremely variable
as it depends on the type of tobacco used. Consequently, the amount up-taken by the user depends
on hookah use characteristics that are adjusted depending on nicotine levels in tobacco used in
order to deliver desired doses (Shihadeh 2003b). Similar to cigarette smoking, plasma nicotine
levels were found to be increased in hookah users, indicating systematic delivery of nicotine.
However, these levels were much higher compared to cigarette users, which could be explained
by longer “hookah” sessions with a higher puff number/volume (Eissenberg and Shihadeh 2009,
Cobb et al. 2011). Likewise, plasma carboxyhemoglobin levels in hookah users exceeded those of
cigarette smokers’ levels (Schubert et al. 2011), indicating the presence/inhalation of carbon
monoxide (CO) during hookah use. This is because CO displaces O2 from hemoglobin forming
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carboxyhemoglobin (CO affinity for hemoglobin is 200 times that of O2), and shifting the oxygen
dissociation curve to the left, thereby causing hypoxia and impairment of cellular respiration
(Weaver 2009). Notably, hookah use was linked to several cases of CO poisoning (Cavus et al.
2010, Lim, Lim, and Seow 2009, Türkmen et al. 2011, La Fauci et al. 2012, von Rappard,
Schonenberger, and Barlocher 2014). Furthermore, NNAL- a metabolite formed after 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enters the body and a well-known
carcinogen - urinary levels increased markedly after hookah use, indicating the presence of
tobacco-specific nitrosamines in hookah smoke(Jacob et al. 2011, Radwan et al. 2013). Other wellknown carcinogens/ potential carcinogens are polycyclic aromatic hydrocarbons (PAHs) and they
have been quantified in hookah smoke, in particular, 16 of these compounds have been found
(Sepetdjian, Shihadeh, and Saliba 2008b). Moreover, in contrast to single cigarette smoking,
nicotine-free dry particulate matter (TAR) from single 45 minutes hookah session reached a level
of 802 mg, which represents 36.5 folds higher than that in a cigarette. This should in turn diminish
marketing fads of hookah containing 0% tar (Jawad, Khaki, and Hamilton 2012). Of note, levels
of tar delivered vary from session to session, reaching up to 100 folds in some cases of longer
hookah smoking sessions (Jacob et al. 2013).
Importantly, inhaled volumes are concerning because they deliver high amounts of
hazardous chemicals/session compared to cigarettes. For instance; aldehydes, such as acrolein,
induce cardiopulmonary toxicity (Conklin 2016, Kassem, Kassem, Liles, Zarth, et al. 2018), are
potentially carcinogenic (Tang et al. 2011, Feng et al. 2006) and are prothrombotic (Sithu et al.
2010b). Furthermore, the PAHs are carcinogenic (Abdel-Shafy and Mansour 2016), whereas
carbon monoxide induces cardiovascular disease (Zevin et al. 2001), and nicotine is known for its
addictive nature (Benowitz 2010). As for ammonia, which is a strong respiratory irritant, its levels
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should be measured as part of the assessment of the hookah toxicant profile, and this could be
achieved using a simple colorimetric method as was recently described for determining ammonia
levels in tobacco fillers and sidestream smoke in different tobacco brands (Inaba, Uchiyama, and
Kunugita 2018).
Based on the aforementioned considerations, hookah use poses as many or even higher
risks for the smoker as cigarette smoking. Besides tar, hookah bears additional risks such as an
uptake of addictive and carcinogenic/ potentially carcinogenic chemicals, which stands in contrast
to the “massive” advertisement of them as a “healthy” smoking product.
Air Quality and Passive Exposure
Ambient concentrations of particulate matter are often used to assess pollution levels from
tobacco smoke (Fiala, Morris, and Pawlak 2012). Cigarette smoking expels high levels of
particulate matter in bars, exposing both customers and employees passively to hazardous levels
of pollutants (Centers for Disease and Prevention 2004). In a similar fashion, the examined air
quality in hookah lounges ranged from “unhealthy” to “hazardous” by the Environmental
Protection Agency (EPA), containing high concentrations of particulate matter (Fiala, Morris, and
Pawlak 2012, Zhou et al. 2015, Zhou et al. 2016). Such air quality poses health risks, especially
among those with existing pulmonary and cardiovascular disease, and presents potential health
hazards for workers who can be exposed to secondhand hookah/smoke on a daily basis, and for
prolonged periods of time (Fiala, Morris, and Pawlak 2012). As expected, low air quality was
reported in houses of hookah users, and interestingly toxicant levels were greater than those in
cigarette smoking homes, yet less than those in lounges/bars (Figure 1.5- (Weitzman et al. 2016,
Zhou et al. 2015, Fiala, Morris, and Pawlak 2012)); which is probably due to lower numbers of
hookah apparatuses used (Weitzman et al. 2016). Nonetheless, such low air quality exposes non-
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users within the household to hazardous materials, and puts them under increased risk of disease,
especially if they are highly vulnerable (with chronic disease, children and pregnant women).
Consequently, there is a marked need for further research, policies and better air quality monitoring
to improve the indoor air quality in order to reduce passive exposure and its negative health
consequences.

Figure 1.5: Comparison between PM2.5 levels in houses of hookah users, cigarette users and bars in two
states. NYC hookah bars (n=8). Oregon hookah bars (n=10) (Weitzman et al. 2016, Zhou et al. 2015, Fiala,
Morris, and Pawlak 2012).

Hookah Health Hazards
While hookah users and those in close proximity are exposed to many of the potentially
dangerous toxicants at one time, the health risks associated with its use continue to be under debate.
This is-in part- attributed to the fact that the composition of tobacco smoke in hookah and its
puffing patterns are variable and not well standardized. Nonetheless, several studies have provided
evidence of health impairments that are associated with hookah use.
Theoretically, sharing the mouthpiece during hookah group smoking can be a probable
source of transmission of pathogens such as viruses, bacteria, and fungi. For instance, a study
reported a potential risk for transmission of communicable diseases such as hepatitis C when
sharing the mouthpiece between users with bleeding gum (Habib et al. 2001). Also, the “non-
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hygienic” conditions of the hose and water in the hookah apparatus could also increase
mycobacteria growth, which can result in the spreading/transmission of tuberculosis (Urkin,
Ochaion, and Peleg 2006, Blachman-Braun et al. 2014). Other studies have also linked hookah to
transmission of Helicobacter pylori (the main cause of peptic ulcer) and Aspergillus spores (cause
of pneumonia in immunocompromised patients) (El Barrawy, Morad, and Gaber 1997, SzyperKravitz et al. 2001). Moreover, 48 bacterial isolates were detected from hookah hoses, and among
them were virulent as well as antibiotics resistant strains (Masadeh et al. 2015). Furthermore, using
hookah was linked to developing periodontal diseases in a similar magnitude to cigarettes (Natto
2005) as well as a documented alteration in oral microbial flora (Shakhatreh et al. 2018).
Similar to cigarette smoking, hookah use is also linked to a harmful impact on the
pulmonary system. Thus, hookah users complain of symptoms such as wheezing, cough, sputum,
and shortness of breath (Boskabady et al. 2012, Boskabady et al. 2014, Strulovici-Barel et al.
2016). Furthermore, hookah significantly decreases pulmonary function parameters, including
FEV1, FEV1/FVC ratio, and FEF, as well as the levels of FeNO (Meo et al. 2014, Raad et al. 2011,
Hakim et al. 2011). FeNO is an essential marker of eosinophilic airway inflammation, and
reduction in its levels may be due to the rapid conversion of nitric oxide to peroxynitrite by reactive
oxygen and nitrogen species or down-regulation of nitric oxide synthase (Barua et al. 2003, Hoyt
et al. 2003). Also, hookah users had lower lung diffusing capacity and elevated levels of apoptotic
endothelial cell microparticles (Strulovici-Barel et al. 2016). Hookah exposure induced a
significant elevation of macrophages, lymphocytes and neutrophils in broncho-alveolar lavage
fluid and altered the levels of several cytokines. Thus, the levels of the pro-inflammatory cytokines
TNFα, IL-1 β, IL-6, IL-12, and IL-13 were elevated, whereas the levels of the anti-inflammatory
cytokine IL-10 were reduced, in the lungs of exposed mice (Khabour, Alzoubi, Al-Sawalha, et al.
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2018, Al-Sawalha, Migdadi, et al. 2017). It also increased catalase activity in the lung and resulted
in changes in the level and mRNA of major matrix metalloproteinase (MMP-1, -9, and -12),
confirming pulmonary damage associated with hookah use (Khabour, Alzoubi, et al. 2012a,
Khabour et al. 2015). Moreover, chronic (4 months) exposure to hookah smoke in mice resulted
in significant increases in alveolar destructive index and mean linear intercept contributing to the
chronic obstructive pulmonary disease picture in these animals (Alzoubi et al. 2018).
Importantly, hookah hazards are not limited only to oral/pulmonary systems. To this end,
in a population-based study, hookah use was associated with metabolic syndrome development.
Thus, hookah users had a significantly higher incidence of hypertriglyceridemia, hyperglycemia,
as well as hypertension and abdominal obesity, which was observed after controlling for age, sex,
social class and area of residence (Shafique et al. 2012). All of these “disorders” increase the risk
of metabolic syndrome development, which is a major risk factor for developing thrombosis (Kaur
2014).
Unfortunately and as stated before, the number of hookah users among the vulnerable
populations of pregnant females and adolescents is increasing. In fact, pregnant females still use
hookah during pregnancy, regardless of its reported hazards. While it may vary based on levels of
use/exposure, a reduction of weight of the newborn (at least 100 gm) in females using hookah
once/day during pregnancy was evident. Moreover, the risk of delivering low birth babies tripled,
in addition to reported neonatal respiratory distress that is linked to hookah use during first
trimester (Nuwayhid et al. 1998, Tamim et al. 2008). In addition to reduction in birth weight, it
was reported that hookah smoking during pregnancy contributes to a significant reduction in
newborns’ other anthropometric measurements such as mean newborn length, and mean newborn
head circumference (Al-Sheyab et al. 2016). In a rat exposure model, hookah smoke exposure was
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shown to be associated with low birth weight, increased neonatal death rate, and lower growth rate
among offspring (Khabour et al. 2016). Additionally, prenatal exposure to hookah smoke in a
murine model of asthma in adult mice offspring also induced airway inflammation and adversely
affected lung function (Al-Sawalha, Al-Bo'ul, et al. 2017). In utero exposure to hookah tobacco
smoke in rats resulted in impaired memory and decreased Brain-Derived Neutrophil Factor
(BDNF) in the hippocampus of adult male offspring rats (Al-Sawalha et al. 2018).
A study of hookah use among 7th -10th grade students indicated that it may impair
adolescents' brain development, given that it reduces the levels of the BDNF (Yeom et al. 2016),
which is essential for cognition and behavior (Yeom et al. 2016). A relatively recent study also
reported a reduction in BDNF serum levels in students reflecting a possibility of systematic
adverse health alterations in adolescence, coupled with behavioral changes such as low attention
and aggression; (Alomari et al. 2018b) . Moreover, hookah tobacco smoke exposure in rats induced
short- and long-term spatial memory impairment (Alqudah et al. 2018), which was associated with
reduced hippocampal levels of major oxidative stress biomarkers and oxidative capacity enzymes
(Alzoubi et al. 2015, Alzoubi et al. 2019).
With respect to the carcinogenicity of hookah, it was reported that carcino-embryonic
antigen (CEA) levels were higher in hookah smokers, in comparison to non-smokers, yet not as
high as in cigarette smokers (Sajid et al. 2007). Thus, prolonged or heavy use of hookah may
induce a risk of tumor development, especially in the oral cavity and esophagus, which further
argues against the notion that hookah has “no/less harm” if not inhaled “kept in mouth”. Indeed,
the incidence of benign lesions of the vocal cords was linked to the presence of cysts in 4.8% of
hookah users, which was similar to cigarette smokers (Hamdan et al. 2010). Furthermore, three
case-control studies reported a link between the risk of esophageal cancer and hookah use, with
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the risk increasing with cumulative use, higher frequency and the duration of use (Dar et al. 2012,
Nasrollahzadeh et al. 2008, Malik et al. 2010). Additionally, using hookah was linked to an average
of six folds higher risk of lung cancer (Lubin et al. 1992, Gupta et al. 2001, Aoun et al. 2013, Koul
et al. 2011). Moreover, it was reported that hookah use may increase the risk of gastric cancer by
three-fold, albeit the mechanism remains unknown (Sadjadi et al. 2014). In addition, hookah
smoking was shown to be genotoxic, leading to DNA damage in lymphocytes, where the
magnitude of its genotoxicity was higher than that induced by cigarette smoking (Khabour et al.
2011, Alsatari et al. 2012). Exposure to hookah smoking resulted in elevated plasma and saliva
levels of toxic metals, namely, cadmium, copper and zinc (Khabour, Alzoubi, Al-Sheyab, et al.
2018), which could contribute to its long-term carcinogenicity. Finally, another study (analyzed
data collected from 152 academic institutions; n=100,891 students) found a moderate association
between hookah smoking and mental health variables, such as depression, anxiety, and addictive
disorders, among college students (Primack et al. 2013). These findings provide evidence that
hookah not only disrupts the “physical” health of the user but also their mental state.
It is noteworthy that many of the aforementioned studies had limitations, for example, no
control over use of other forms of tobacco, lack of adjustments of the cofounding factors in some
case-studies, as well as limited assessment of gender and age as cofounders. Nonetheless and taken
together, there is sufficient evidence in support of the association of hookah use with negative
human health outcomes. Considering the cardiovascular system sensitivity and its nonlinear dose‐
response/toxicity relationship with “smoke”, the next section will review the literature with regard
to the effects of hookah on the cardiovascular system (see Figure 1.6), both human and animal
studies.
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Figure 1.6: Cardiovascular effects and their underlying mechanisms. These data are compiled from what is
reported in clinical studies. * Study performed in adolescents, the reduced heart rate and blood pressure may be
linked to the “abstinence of vaping” for 12 hours prior to testing (Alomari and Al-Sheyab 2018).

Cardiovascular Effects of Hookah Use
The detrimental (acute and chronic) effects of tobacco smoking on the cardiovascular
system are well-established (Ambrose and Barua 2004b, Messner and Bernhard 2014, Benowitz ,
2010, Bullen 2008, Michael Pittilo 2000). Thus, cigarette smoking predisposes to cardiovascular
events and contributes significantly to cardiovascular related mortality and morbidity, being
responsible for up to 30% of heart disease-related deaths in the United States each year (Benowitz
, Qasim et al. 2017). Importantly, hookah has overlapping toxicant/chemical profile to
conventional cigarettes. In light of that, it has been shown that hookah smoke effects on the
cardiovascular system are comparable to those of conventional cigarettes. It is noteworthy that a
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recent meta-analysis reported an odds ratio of association between hookah tobacco smoking and
heart disease of 1.67 (95% CI = 1.25, 2.24) (Waziry et al. 2016), which supports the notion that
hookah is indeed detrimental to the cardiovascular system.
Clinical Studies
Acute cardiovascular effects
Acute effects of conventional smoking, such as increased blood pressure, heart rate (HR)
and vascular resistance have been known for decades (Jaquet, Shapiro, and Uijtdehaage 1994, AlSafi 2005, Quillen et al. 1993, Rhee et al. 2007). As with tobacco smoking, the instantaneous
effects of hookah use include higher systolic and mean arterial blood pressure, as well as elevated
HR (Hakim et al. , Shaikh et al. 2008, Kadhum et al. 2014, Azar et al. 2016, Al-Kubati et al. 2006,
Eissenberg and Shihadeh 2009, Hawari et al. 2013, Layoun et al. 2014). It is noteworthy that in
one cohort study HR elevation has exceeded 50 bpm in 6.4% of participants, and reached higher
than 200 bpm in 3.6% of participants after only a 30 minute-hookah session (OA-A. 2012). These
effects have been attributed, in part, to the baroreflex mechanism impairment (Al-Kubati et al.
2006), or to elevated nicotine plasma level. The latter exhibits adrenergic effects that will enhance
local and systemic catecholamine release (Cobb et al. 2012, Saafan 2005, Al-Kubati et al. , AlSafi et al. 2009, Blank et al. 2011, Azar et al. 2016). Supporting the latter notion, mean post
hookah-smoking heart rate elevation was doubled in participants using nicotine-containing hookah
in comparison to nicotine-free hookah smokers (Shishani et al. 2014). Additionally, in a two
double-blind study, “placebo” had no effect on HR, while hookah-smoking increased it
significantly (Blank et al. 2011). Another study reported that changes in the cardiovascular central
and peripheral components occur immediately after hookah smoking, and include increases in HR,
blood pressure, and after occlusion vascular resistance, whereas after occlusion blood flow and
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outflow were decreased (Alomari et al. 2014). The cardiovascular changes were shown to be
exacerbated among individuals with low habitual physical activity and physical fitness levels
(Alomari et al. 2015). More recently, it has been reported that adolescents smoking hookah had
significantly lower vascular endothelium growth factor (VEGF) levels (Alomari et al. 2018a),
which might adversely affect vascular growth and function in this population.
Acute use of hookah also induced changes in the peripheral vascular system in a similar
fashion to cigarette smoking, such that it increased vascular resistance and reduced post occlusion
blood flow. This could be linked to local release/synthesis of oxygen-derived free radicals, cell
cycle arrest and a decrease in NO activity (Alomari et al. , Mayhan and Sharpe 1998, Diab,
Abdelrahim, and Esmail 2015, Rammah et al. 2013). In a manner comparable to cigarette smoking,
short-term hookah use significantly impaired flow-mediated dilation (FMD), which indicates
endothelial dysfunction, but hookah was a weaker predictor for high-risk profile (Diab,
Abdelrahim, and Esmail 2015). Furthermore, it was reported that short-term hookah use (both
tobacco-based and tobacco-free products) disrupts the autonomic nervous system regulation on the
cardiac cycle, thereby causing a reduction in HR variability; which- in turn- might aggravate the
risk of coronary artery disease development (Cobb et al. 2012). Moreover, a significant increase
in TXB2 levels, a metabolite of the biologically active TXA2 and an index of oxidative injury, was
reported after a single hookah smoking session (Wolfram et al. 2003). This increase in TXB2 levels
would suggest an increase in platelet activity (Catella et al. 1986). Importantly, it has been shown
that an increase in platelet activity plays a major role in the pathogenesis of acute myocardial
infarction (MI) (Tousoulis et al. 2010) and acute stroke (Mulley et al. 1983, Cevik et al. 2013,
McCabe et al. 2004). Therefore, it is not surprising to see a link between hookah smoking and
acute MI in young adults (Abed, Eshah, and Moser 2018), and among patients undergoing cardiac
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catheterization (Platt et al. 2017). However, no data exist yet on the association between hookah
smoking and acute stroke (Hashmi, Khan, and Wasay 2013). Interestingly, and contrary to the
hypothesis that hookah decreases myocardial blood flow because of the charcoal combustion
nanoparticles (vasoconstrictor), a study found that hookah use acutely increased myocardial blood
flow. This is thought to be due to cardiac β-adrenergic stimulation as a physiological response to
increased myocardial work and oxygen demand (Nelson et al. 2016). In light of the aforementioned
evidence, it is clear that even short-term use of hookah disrupts normal cardiovascular function, as
repetitive short-term hookah exposure may be the triggering point of causal chain of reactions
ultimately leading to the chronic effects. Nonetheless, more research should be done to evaluate
hookah’s effects, which will guide awareness campaigns regarding its negative health outcomes,
including those that result from short-term use/exposure.
Cardiovascular effects of chronic use
With regard to the adverse cardiovascular effects associated with longer-term of hookah
use, they are comparable to those associated with cigarette smoking. In this connection, a link
between chronic use of hookah and coronary artery disease (CAD) development has been shown,
with the frequency and duration of exposure being critical risk factors to CAD. In fact, individuals
with more than 40 years of hookah smoking had three times more risk of having severe stenosis
than nonsmokers (Sibai et al. 2014). Additionally, cardiovascular disease development such as
ischemic heart disease (IHD) and heart failure have been associated with heavy hookah smoking
(Islami et al. 2013). These outcomes could be explained by the continuous stress placed on the
cardiovascular system as a result of exposure to high amounts of CO (Soule, Lipato, and
Eissenberg 2015). Furthermore, death due to IHD was 1.96 folds in ever hookah smokers with a
higher daily intensity of hookah smoking than never users (Wu et al. 2013). Hookah smoking was
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also associated with severe CAD, which was dependent on the duration/frequency of hookah
smoking (Selim, Fouad, and Ezzat 2013). In accordance with the latter data, a dose-response
relationship between hookah-years and percent stenosis was also established(Sibai et al. 2014).
Furthermore, the risk of MI and stroke death was significantly increased with hookah smoking.
Finally, higher fibrinogen plasma levels were reported in long term hookah smokers (> 10 years),
which elevates the incidence of pro-thrombotic/atherosclerotic events, (Seyyed Hashem Sezavar
2004) and might explain in part the higher risks of stroke and MI linked with chronic hookah
smoking.
Notably and interestingly, a recent cross-sectional study aimed to examine the relationship
between chronic hookah smoking and cardiovascular hemodynamics in adolescents found a
reduction in both BP and HR of adolescent hookah smokers versus non-smokers, which is in
contrast to previously reported results in adults. This might be explained by the “abstinence of”
hookah smoking for 12 hours prior to testing, thereby reducing nicotine levels drastically in the
system, which would impact neuro-hormonal regulation (reduced cortisol and sympathetic
activity). Nonetheless, the exact mechanism underlying such an outcome is still unclear but
warrants investigation (Alomari and Al-Sheyab 2018).
Together, hookah use has been associated with many cardiovascular effects that influence
or contribute to the decline of the overall health status of members of our communities.
Unfortunately, despite studies documenting cardiovascular disease risks associated with hookah,
people continue to assume that it is safer than cigarettes, mainly due to being unaware of its
negative health effects. Thus, hookah awareness/ control should be more robust and systematic,
but more importantly, further studies need to be conducted to better understand its negative health
consequences, and the mechanisms inducing such effects.

30

Animal Studies
Acute and chronic exposures to hookah smoke, resulted in significant changes in kidney
function biomarkers such as creatinine and blood urea nitrogen, in mice. This was associated with
a reduction in antioxidant enzymes and biomarkers including superoxide dismutase for acute and
chronic hookah smoke exposures, and catalase, glutathione peroxidase, and thiobarbituric acid
reactive substances for chronic exposure (Rababa'h et al. 2016). Acute and chronic exposure of
mice to hookah corroborates with the clinical findings that suggest cardiovascular dysfunction. To
this end, short-term nose-only exposure to mainstream hookah for 5 consecutive days induced a
significant decrease in platelet numbers and amplified in vitro platelet aggregation indicating a
prothrombotic state (Nemmar, Yuvaraju, et al. 2015, Nemmar, Al-Salam, Beegam, et al. 2017).
Furthermore, cardiac inflammation with an increase in reactive oxygen species (ROS) was
observed, which consequently caused an elevation in heart glutathione (GSH; an antioxidant)
concentrations. This seems to indicate that an initial adaptive response that counterbalances the
potentially damaging activity of ROS (Nemmar, Yuvaraju, et al. 2015) is triggered. Interestingly,
long-term nose-only exposure for one month caused a significant increase of ROS in the heart
accompanied with decreased heart GSH concentrations in exposed mice, indicating depletion of
the antioxidant, which increases heart tissue vulnerability to oxygen free radicals damage
(Nemmar et al. 2013). The increased cardiac vulnerability may explain the increased systolic blood
pressure reported after long-term use, which was not seen post short-term exposure (Nemmar,
Yuvaraju, et al. 2015, Nemmar et al. 2013).
The Gap in the Literature
Both clinical and animal studies have provided (although limited) evidence of a link
between cardiovascular disease development and waterpipe/hookah (short and long-term use).
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However, there remain some knowledge gaps; firstly, lack of well-designed studies and
comprehensive meta-analysis addressing the association between hookah use and cardiovascular
diseases. But more importantly, the pathophysiologic mechanisms that link waterpipe/hookah to
cardiovascular adverse events are not fully understood. Therefore, there is a need for studies on
the effects of waterpipe/hookah smoke exposure on cardiovascular diseases in the context of
platelets. These types of studies are critical, knowing that thrombosis is one of the main
mechanisms of smoke/tobacco-induced cardiovascular diseases, and the fact that platelets are a
major player in the process of thrombosis. Further, waterpipe/hookah shares some of its toxic
profile with cigarettes, which is established as a platelet activation modulator.
The Research Question
As a result of our literature research and the available evidence, we decided to ask the following
question:
Does adult and in utero exposure to waterpipe/hookah smoke increase the risk of thrombosis and
modulate platelet function?
Hypothesis
Adult and in utero exposure to waterpipe/hookah smoke modulates platelet function, thereby
increasing the risk of thrombosis.
Methods
Reagents and Materials
Thrombin was purchased from Chronolog Corporation (Havertown, PA), whereas
adenosine diphosphate (ADP), nicotine, and cotinine were from Sigma Aldrich (St Louis, MO).
Fluorescein isothiocyanate—conjugated anti-P-selectin and fluorescein isothiocyanate—
conjugated Annexin V were purchased from Cell Signaling Technology, Inc (Danvers, MA). The
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phycoerythrin-conjugated αIIbβ3 antibody was obtained from Emfret analytics (Würzburg,
Germany). Stir bars and other disposables were purchased from Chrono-Log Corporation
(Havertown, PA). Akt (protein kinase B), phospho-Akt (Ser473), ERK (extracellular signal
regulated kinases), and phospho-ERK antibodies were purchased from Cell signaling (Danvers,
MA). The anti-PAR4 (protease-activated receptor 4) and anti-GPIIb-IIIa (αIIbβ3) antibodies were
from Abcam (Cambridge, MA), whereas the anti-p85/PI3K (phosphoinositide 3-kinases) antibody
was from Proteintech (Rosemont, IL). The enzyme-linked immunosorbent assay (ELISA) cotinine
detection kit was purchased from Calbiotech (El Cajon, CA). The fibrinogen plasma
detection/quantification ELISA kit was purchased from Innovative Research (Novi, MI).
Animals
For the WPS adult exposure C57BL/6J (10‐week‐old male) mice (referred to hereafter as
C57BL/6) were purchased from the Jackson Laboratory (Bar Harbor, ME), and were housed in
groups of 1 to 4 at 24°C, under 12/12 light/dark cycles, with access to water and food ad libitum.
For the in utero WPS exposure 15 males and 30 female BALB/c mice (8-weeks old) were
purchased from the Jackson Laboratory (Bar Harbor, ME). Female mice were randomly assigned
into two groups: Clean air and WPS group. One pair of male and female mice were kept in the
same cage for mating. The pregnancy was detected by vaginal plug method (Byers et al. 2012). If
the female mouse was not pregnant, mating was repeated the next day. After birth, the male
offspring mice were kept in clean air and monitored until the age of 10 weeks. Adult male offspring
mice were divided into; (1) clean air (exposed in utero to clean air), (2) WPS (exposed in utero to
WPS. All animal experimental protocols were approved by the Institutional Animal Care and Use
Committee (IACUC) of The University of Texas at El Paso.
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Waterpipe Smoke (WPS) Whole Body Exposure Protocol
The exposure of adult mice to waterpipe smoke (WPS) utilized a whole-body exposure
chamber (40cm x 30cm x 25cm, LxWxH), which was connected to a programmable waterpipe
smoking machine, as described in previous report (Khabour, Alzoubi, et al. 2012b). The smoking
machine delivered 171 puffs of 530 mL volume, 2.6 s puff duration, and 17 s interpuff interval
according to the Beirut Method (Katurji et al. 2010a). This method is based on the smoking
behavior in real-life waterpipe/hookah settings (Hookah café), and the protocol itself has been used
worldwide and in different studies (Katurji et al. 2010b, Shihadeh and Azar 2006, Khabour,
Alzoubi, et al. 2012a, Khan, Sundar, and Rahman 2018, Khabour, Alzoubi, Al-Sawalha, et al.
2018, Ali et al. 2017, Nemmar, Al Hemeiri, et al. 2015, Shihadeh and Saleh 2005, Shihadeh et al.
2004, Rababa'h et al. 2016, Rababa'h et al. 2019). The clay bowl of the waterpipe used in this study
was loaded with 12g of commercially available flavored tobacco (Al Fakher - Double Apple
Tobacco Trading, Ajman, UAE), whose ingredients include tobacco, glycerin, molasses and
natural flavor with nicotine and tar. We also conducted exposures using a second tobacco brand,
namely the Starbuzz (Dale Ave Stanton, CA), and performed specific platelet function experiments
(aggregation and dense granule secretion). After covering the clay bowl with Aluminum foil,
quick-light charcoal briquettes (Holland Hookah Charcoal) were used to burn the tobacco. The
bowl of the waterpipe was filled with about 700 mL of tap water, prior to each exposure session.
Along with the smoke puff delivered to the exposure chamber by the smoking machine, fresh/clean
air was continuously pumped into the chamber, resulting in an air change rate of approximately
1.5 changes per hour. Carbon monoxide (CO) concentration (average levels were 925 ppm) was
continuously monitored in the chamber using an electrochemical sensor (Bacharach Monoxor
Plus) drawing a flow rate of 0.3 LPM through a 25 mm glass fiber filter (Pall Type A/E). The WPS
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mice were exposed, as described above, for one exposure session 60 min/day for seven days, and
all experiments performed on the day of the last exposure session. As for the in utero WPS
exposure, female mice (C57BL/6) were exposed to the same exposure protocol one week before
pairing with male mice. Exposure continued during the gestation period. After birth, exposure
stopped and offspring used for experiment at the age of 10 weeks. The control mice were exposed
to clean air.

Cotinine Assay
The serum levels of cotinine, a metabolite of nicotine, were measured in both WPS and
clean air exposed mice, using the Cotinine Direct ELISA kit as per the manufacturer's instructions.
Tail Bleeding Time
After a complete cycle of exposure, we performed tail bleeding time assay as we described
before (Qasim et al. 2018, Karim, Alshbool, et al. 2015). Briefly, anesthesia was induced and WPS
and clean air exposed mice were placed on a homeothermic blanket at 37°C, after which that tail
was transected 5 mm from the tip using a sterile scalpel. After transection, the tail was immediately
immersed in saline (37°C constant temperature), and the time to bleeding stoppage was measured.
The bleeding stoppage was not considered complete until bleeding had stopped for 1 minute. If
bleeding did not stop in 10 minutes, the experiment was stopped to prevent excessive blood loss
from the mice, and 10 minutes was considered the cutoff bleeding time.
In Vivo FeCl3 Carotid Artery Injury Induced Thrombosis Model
Thrombosis studies were performed as described previously (Qasim et al. 2018, Karim,
Alshbool, et al. 2015). Briefly, WPS and clean air exposed mice (8–10 weeks old) were

35

anesthetized with avertin (2.5%), and the left carotid artery was exposed and cleaned with normal
saline (37°C) before baseline carotid artery blood flow was measured with Transonic Micro‐
Flowprobe (Transonic Systems Inc, Ithaca, NY). After stabilizing blood flow, 7.5% ferric chloride
was applied to a filter paper disc (1‐mm diameter) that was immediately placed on top of the artery
for 3 minutes. Blood flow was continuously monitored for 20 minutes or until blood flow reached
stable occlusion (no blood flow for 2 minutes). Data were recorded, and time to vessel occlusion
was calculated as the difference in time between stable occlusion and removal of the filter paper
(with ferric chloride). An occlusion time of 20 minutes was considered as the cutoff time for
statistical analysis.
Peripheral Blood Cell/Platelet Counts
The hematology profile, including platelets and white blood cells, of the WPS/clean air
exposed mice was performed on whole blood using a HEMAVET® 950FS Multi‐species
Hematology System from Erba® Diagnostics (Miami Lakes, FL).
Murine Platelet Rich Plasma Preparation
Mice were anesthetized before blood was collected from the heart, with 0.38% sodium
citrate solution (Fisher Scientific, Hampton, NH) added to inhibit coagulation. Then blood was
centrifuged (237g for 15 minutes) at room temperature, and the platelet‐rich plasma was then
collected. Platelets were counted with the HEMAVET® 950FS Multi‐species Hematology
System, and their count adjusted to 7×107 platelets/mL before each experiment.
Washed Platelet Preparation
Blood was collected form each mouse as described above and were pooled in each group
followed by diluted phosphate‐buffered saline, pH 7.4, in 1:1 ratio, incubated with PGI2 (10
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ng/mL; 5 minutes), and centrifuged at 237g for 10 minutes at room temperature. Platelet‐rich
plasma was recovered, and incubated with 0.37 U/mL apyrase, and 10 ng/mL PGI2, platelets were
pelleted at 483×g for 10 minutes at room temperature. The pellets were resuspended in
HEPES/Tyrode buffer (20 mmol/L HEPES/KOH, pH 6.5, 128 mmol/L NaCl, 2.8 mmol/L KCl, 1
mmol/L MgCl2, 0.4 mmol/L NaH2PO4, 12 mmol/L NaHCO3, 5 mmol/L D‐glucose) supplemented
with 1 mmol/L EGTA, 0.37 U/mL apyrase, and 10 ng/mL PGI2. Platelets were then washed and
resuspended in HEPES/Tyrodes (pH 7.4). Platelets were counted using the HEMAVET® 950FS
Multi‐species Hematology System and adjusted to the indicated concentrations.
In vitro Platelet Aggregation
The platelet‐rich plasma (PRP) from WPS exposed and clean air mice were activated with
thrombin (0.1 U/mL) or ADP (5 μmol/L). Platelet aggregation was measured by the turbidometric
method using model 700 aggregometer (Chrono‐Log Corporation, Havertown, PA). Each
experiment was repeated at least 3 times with blood pooled from at least 3 different groups (i.e.,
at least 8 mice each) that were exposed to either WPS or clean air. The aggregation assay was
conducted after exposure to the two different tobacco brands.
Dense Granule Release
Platelet‐rich plasma (250 μL; 7×107/mL) were placed into siliconized cuvettes and stirred
for 5 minutes at 37°C at 1200 rpm, followed by the addition of luciferase substrate/luciferase
mixture (12.5 μL, Chrono‐Log), and activated the PRP using the agonists thrombin (0.1 U/mL) or
ADP (5 μmol/L). The release of ATP was measured using 700 aggregometer (Chrono‐Log
Corporation, Havertown, PA). This assay was conducted after exposure to the two different
tobacco brands.
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Flow Cytometric Analysis
Flow cytometric analysis was carried out as described (Karim, Alshbool, et al. 2015, Qasim
et al. 2018). Briefly, washed platelets (2×107/mL) from clean air- or WPS–exposed mice were
prepared as described above and stimulated with thrombin (0.1 U/mL) or ADP (5 μmol/L) for 5
minutes. Platelets were then fixed with 2% formaldehyde for 30 minutes at room temperature,
followed by incubated with FITC‐conjugated CD62P (P‐selectin), Annexin V or phycoerythrin‐
conjugated rat anti-mouse JON/A antibodies at room temperature for 30 minutes in the dark.
Finally, platelets were diluted 2.5-fold with HEPES/Tyrode buffer (pH 7.4). The samples were
transferred to FACS-tubes and fluorescent intensities were measured using a BD Accuri C6 flow
cytometer and analyzed using CFlow Plus (BD Biosciences, Franklin Lakes, NJ). Each experiment
was repeated at least 3 times with blood pooled from at least 3 different groups (at least 8 mice
each) that were exposed to either clean air or WPS.
Platelet Spreading
Platelet spreading assay was carried out as we described before (Choi, Karim, and
Whiteheart 2006, Qasim et al. 2019). Briefly, sterile glass coverslips were coated with 0.2 μg/mL
of fibrinogen for 30 minutes at room temperature. Washed platelets were placed onto these
fibrinogen‐coated coverslips before they were fixed with 3.7% (vol/vol) formaldehyde for
15 minutes and quenched with 50 mmol/L ammonium chloride. Cells were rinsed with PBS and
incubated with tetramethylrhodamine‐conjugated phalloidin (1 μg/mL) in 10% fetal bovine
serum/PBS with 0.2% saponin. Coverslips were mounted and examined and imaged using a Leica
DMi8 inverted widefield fluorescence microscope with an integrated high‐precision focus drive.
Images were processed using LAS X Wizard imaging software. Objective lenses used were a
×63/×100 numeric aperture. Type A immersion oil (Fryer) was used for the ×63 objective. This
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experiment was repeated at least 3 times, with blood pooled from a group of 8 mice each time.
Comparison is based on difference in the level of spreading.
Immunoblotting
Immunoblot was carried out as described before (Qasim et al. 2018, Karim et al.
2016). Briefly, clean air– or hookah/waterpipe–exposed washed platelets were stimulated with
thrombin (0.1 U/mL) for 3 minutes followed by lysis with 1X sample buffer. Next, proteins were
separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to
Immobilon‐P PVDF membranes (Bio‐Rad, Hercules, CA). Membranes were then probed with the
primary antibodies (ERK, pERK, Akt, and pAkt) and visualized with horseradish peroxidase–
labeled antirabbit or antimouse immunoglobulin G as required. The antibody binding was detected
using enhanced chemiluminescence substrate (Thermo Scientific, Rockford, IL). Images were
obtained with ChemiDoc MP Imaging System (Bio‐Rad, Hercules, CA), and quantified using
Image Lab Software 6.0.1 (Bio‐Rad, Hercules, CA). For expression levels of PI3K (P85), PAR4,
and integrin αIIbβ3, platelet proteins were separated by SDS‐PAGE and transferred to Immobilon‐
P PVDF membranes (Bio‐Rad, Hercules, CA). They were then probed with anti‐PI3K, anti‐ PAR4,
or anti-integrin αIIbβ3 primary antibodies and visualized with an appropriate alkaline
phosphatase–coupled secondary antibody using enhanced chemifluorescent substrate (Thermo
Scientific, Rockford, IL).
Mouse Treatment with Nicotine and Cotinine
Mice were also injected with 1 µM cotinine (a “real-life” dose selected based on waterpipe
literature) (Kassem, Kassem, Liles, Jackson, et al. 2018, Moon et al. 2018, Nosratzehi et al. 2015,
Kassem et al. 2014) or vehicle once daily for one week. Experiments on cotinine treated animals
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were performed on the day of the last injection. As for nicotine, mice were injected with 1 mg/kg
nicotine, as previously used in the literature (Ljungberg et al. 2013), and the blood collected after
one hour post injection.
Fibrinogen Assay
The plasma concentration of fibrinogen was determined using ELISA kit as per the
manufacturer's instructions.
Statistical Analysis
All experiments were performed at least 3 times with blood pooled from 3 groups of at
least 8 mice each time, as applicable. Data analysis was performed using GraphPad PRISM. V7
statistical software and presented as mean ± standard deviation (SD). The Mann‐Whitney test was
used for the evaluation of differences in mean occlusion and bleeding times, whereas the one‐way
ANOVA with Tukey's multiple comparisons test as post hoc was used for the analysis of the flow
cytometry data, as applicable (per number of groups). Significance was accepted at P <0.05 unless
stated otherwise.
Results
Adult WPS Exposure Systemically Delivers Nicotine In Exposed Mice.
As a means of validating the WPS exposure protocol, the serum levels of the nicotine
metabolite cotinine (Benowitz, Hukkanen, and Jacob 2009) are typically measured in exposed
animals and/or “tobacco users”. Hence, our results showed significant increases of cotinine levels
in the WPS exposed mice (15.2 ± 0.72 ng/mL; Fig 2.1), in serum obtained immediately after the
conclusion of the exposures, whereas it was undetectable in that from the clean air controls. These
levels overlap with those found in human waterpipe users (5.5-77.8 ng/mL) (Nosratzehi et al. 2015,
Moon et al. 2018, Macaron et al. 1997, Levine et al. 2013, Kassem, Kassem, Liles, Jackson, et al.
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2018). Our data support the notion that our adult WPS exposure protocol results in the systemic
delivery of nicotine into the exposed mice.

Figure 2.1: WPS increases cotinine concentration in exposed mice. The concentrations of cotinine were
measured in serum from WPS and clean air exposed mice. Each bar represents the mean ± SD (n = 10;
****P<0.0001)

On the other hand, cotinine was not detected in the serum of the in utero WPS exposed offspring
mice. This would be expected as those animals were exposed only in utero and examined at 10
weeks of age, when cotinine is expected to be completely cleared from their system.

Adult WPS Exposure Modulates Hemostasis and Thrombosis Development.
Numerous studies showed that cigarette smoking causes disease states that are linked to
thrombosis (Ambrose and Barua 2004a, Levine 1973). On contrast, it is yet to be determined
whether waterpipe smoking carries a similar effect. Therefore, we initially investigated the effects
of waterpipe smoke (WPS) exposure on both hemostasis and thrombogenesis. As for its effect on
hemostasis, the tail bleeding time assay revealed that time to bleeding stoppage was significantly
shortened in the WPS-exposed mice when compared with those exposed to clean air, specifically
11.43 ± 2.15 seconds to 300.7 ± 7.32 seconds, respectively (Figure 2.2A). This line of evidence
indicates a prothrombotic phenotype in the WPS-exposed mice. Thus, we sought next to examine
if these are more prone to thrombosis. Using the ferric chloride carotid artery injury-induced
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thrombosis model, we indeed found that the WPS-exposed mice had a shortened time for
occlusion, in comparison with the controls, specifically, 72 ± 33.7 seconds to 370 ± 62.9 seconds,
respectively (Figure 2.2B). These data document, for the first time, that adult WPS exposure
directly modulates hemostasis and thrombus occlusion.

Figure 2.2: Exposure to WPS alters hemostasis and thrombosis. (A) This data illustrates the results of tail
bleeding time assay (as described in the “Methods”) comparing WPS and clean air exposed mice. Each point
represents the tail bleeding time of a single animal (clean air, n=7; and WPS, n=7; ***P<0.001). (B) This data
illustrates the results of the ferric chloride–induced thrombosis model (as described in the “Methods”) comparing
WPS and clean air exposed mice time to occlusion. Each point represents the occlusion time of a single animal
(clean air, n=7; and WPS, n=7; ***P<0.001).

In utero WPS Exposure Modulates Hemostasis and Thrombosis Development.
It is well established that prenatal/during pregnancy cigarette smoking is associated with negative
health outcomes on the offspring in adult life (Law et al. 2003, Prabhu et al. 2010, Vardavas et al.
2010). Thus, we sought to investigate the effect of in utero WPS exposure on hemostasis and
thrombogenesis. Our results illustrate that offspring exposed to WPS in utero exhibit shortened
occlusion (Figure 2.3A) and bleeding times (Figure 2.3B) in comparison to clean air exposed mice
(only male mice used). These results are consistent with those of the adult exposure and indicate
that the prothrombotic phenotype persists when the exposure takes place during pregnancy.
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Figure 2.3: In utero exposure to WPS alters hemostasis and thrombosis. (A) This data illustrates the results of
the ferric chloride–induced thrombosis model (as described in the “Methods”) comparing in utero WPS and clean
air exposed offspring mice time to occlusion. Each point represents the occlusion time of a single animal (clean
air, n=6; and in utero WPS, n=6; **P<0.05). (B) This data illustrates the results of tail bleeding time assay (as
described in the “Methods”) comparing in utero WPS and clean air exposed mice. Each point represents the tail
bleeding time of a single animal (clean air, n=7; and in utero WPS, n=7; ***P<0.001).

Acute Adult WPS Exposure Does Not Affect Peripheral Blood Cell Counts.
To exclude the possibility that changes in platelet number may have contributed to the hemostasis
and thrombosis phenotype we observed, platelets were counted in the WPS and clear air mice. We
did not observe any significant difference in the platelet count (Table 1) between the WPS-, and
clean air-exposed mice, namely (556 ± 24.3 to 573 ± 31.2 (thousand/µL; P=0.40). These results
indicate that under the present experimental conditions, the prothrombotic phenotype is
independent of platelet count. Moreover, we did not observe any detectable effects for WPS on
the counts of white/peripheral blood cells (Table 1).
Table 2.1: Complete blood count for adult WPS exposed mice.
Cell type

WPS (mean ± SD)

Clean Air (mean ± SD)

P Values

Platelets (k/mL)

556 ± 24.30

573 ± 31.20

0.40

MPV (fl)

4.8 ± 0.26

4.90 ± 0.10

0.54

Red blood cells (M/mL)

8.15 ± 0.85

8.05 ± 0.90

0.88

Lymphocytes (k/mL)

1.77 ± 0.05

1.83 ± 0.37

0.76

Monocytes (k/mL)

0.07 ± 0.01

0.10 ± 0.02

0.17

Granulocytes (k/mL)

2.29 ± 0.10

2.50 ± 0.30

0.30

HCT (%)

40.4 ± 1.45

39.45 ± 2.11

0.72
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In utero WPS Exposure Does Not Affect Peripheral Blood Cell Counts.
Our results were again consistent with the adult exposure, and we did not observe any
significant difference in the platelet count (Table 2) between the in utero WPS, and clean airexposed mice, namely (599 ± 60.87 to 571 ± 83.94 (thousand/µL; P=0.46). These results indicate
that under the present experimental conditions, the prothrombotic phenotype seen in the in utero
exposed offspring is independent of platelet count. Moreover, we did not observe any detectable
effects for WPS on the counts of white/peripheral blood cells (Table 2).
Table 2.2: Complete blood count for the in utero WPS exposed mice.
Cell type

Clean air
(mean ± SD)

In utero WPS
(mean ± SD)

P Values

Platelets (k/mL)
MPV (fl)
Red blood cells (M/mL)
Lymphocytes (k/mL)
Monocytes (k/mL)
Granulocytes (k/mL)
HCT (%)

571.5±83.94
5.03±0.15
5.52±1.19
1.45±0.42
0.06±0.01
1.82± 0.56
26.84±6.06

599.3±60.87
5.125±0.1832
5.049±0.8204
1.323±0.3208
0.075±0.010
1.736± 0.562
24.79±4.04

0.46
0.31
0.36
0.46
0.29
0.71
0.43

Adult WPS Exposure Enhances Agonist‐Induced Platelet Aggregation.
Previous studies have shown that cigarette smoking enhances platelet function (Takajo et al. 2001).
Given that our data showed a robust prothrombotic phenotype in WPS-exposed mice, we
hypothesize that this will derive, in part, from platelet hyperactivity as a result of WPS exposure.
Thus, we sought to examine the effects of WPS exposure on agonist-induced platelet aggregation.
It was found that platelets from WPS-exposed mice exhibited enhanced platelet aggregation in
comparison to those from clean air controls, in response to thrombin or ADP (Figure 2.4A & 2.4B;
inset shows quantification of data). Together, the hyperactive platelet state is consistent with
shortened bleeding and occlusion times phenotype observed in the WPS mice. A similar result was
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obtained when the same experiment was repeated with a different waterpipe tobacco brand (see
Methods for details; Figure 2.4C & 2.4D; inset shows quantification of data).

Figure 2.4: Platelet aggregation is enhanced in WPS exposed mice, using two different brands. Platelets from
WPS (two separate brands) and clean air exposed mice were stimulated with 0.1 U/mL thrombin, or 5 μmol/L
ADP, before their (A, B, C, D) aggregation responses were measured in a lumi-aggregometer. The experiment
was repeated 3 times, with blood pooled from at least 8 mice each time (*P <0.05; **P <0.01).

In utero WPS Exposure Enhances Agonist‐Induced Platelet Aggregation.
Consistent with the results that showed in utero exposure to WPS produces a prothrombotic
phenotype, and in agreement with the effect seen in the adult exposure on platelet aggregation, our
data revealed that platelets from in utero WPS-exposed mice exhibited enhanced aggregation in
comparison to those from clean air controls, in response to thrombin or ADP (Figure 2.5 A & B).
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Figure 2.6: Adult WPS exposure enhances platelet granule release. (A, B, C, and D) Dense granule secretion
response was measured in a lumi-aggregometer. Platelets were incubated with luciferase (12.5 μL) for the dense
granules measurements. (*P <0.05; **P <0.01). (E, F) Alpha granule secretion was measured by incubating
platelets with P-selectin (for α granules), before the fluorescent intensities were measured by flow cytometry
after stimulation with 0.1 U/mL thrombin or 5 μmol/L ADP. Each experiment was repeated 3 times, with blood
pooled from at least 8 mice each time.

Adult WPS Exposure Enhances Agonist‐Induced Platelet Secretion.
We next sought to investigate the impact of WPS exposure on agonist-induced platelet
secretion, given the importance of the platelet granule release in amplifying the initial platelet
response (Dawood, Wilde, and Watson 2007, Storrie and Whiteheart 2017). Our results
demonstrated dense granule/ATP secretion is enhanced in the WPS platelets, in response to
thrombin or ADP (Figure 2.6A, 5B), even with exposure to a different tobacco brand (Figure 2.6C,
5D), which is consistent with the aggregation data. Similarly, platelets from mice exposed to WPS
had significantly higher expression of P‐selectin on their surface in response to 0.1 U/mL of the
agonist thrombin or 5μM ADP (Figure 2.6E & 2.6F).
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Figure 2.5: Platelet aggregation is enhanced in in utero WPS exposed mice. Platelets from in utero WPS and
clean air exposed mice were stimulated with 0.1 U/mL thrombin, or 5 μmol/L ADP, before their (A, B)
aggregation responses were measured. The experiment was repeated 3 times, with blood pooled from at least 8
mice each time.

These findings indicate that whole‐body exposure to WPS enhances both dense and αgranule secretion, which is in line with the notion that these platelets are hyperactive.
In utero WPS Exposure Enhances Agonist‐Induced Platelet Secretion
In agreement with aggregation data, dense and alpha granules secretion were found to be
enhanced in platelets from in utero WPS exposed mice in comparison to clean air (Figure 2.7 A,
B, and C). This data suggest that platelet function is impacted by in utero WPS exposure, and this
mechanism- at least in part- contributes to the observed prothrombotic phenotype.

Figure 2.7: In utero WPS exposure enhances platelet granule release. (A, B) Dense granule secretion response
was measured in a lumi-aggregometer. Platelets were incubated with luciferase (12.5 μL) for the dense granules
measurements. (*P <0.05; **P <0.01). (C) Alpha granule secretion was measured by incubating platelets with Pselectin (for α granules), before the fluorescent intensities were measured by flow cytometry after stimulation
with 0.1 U/mL thrombin or 5 μmol/L ADP. Each experiment was repeated 3 times, with blood pooled from at
least 8 mice each time.
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Adult and in utero WPS Exposure Enhances Agonist‐Induced Integrin αIIbβ3 Activation.
In light of the notion that both adult and in utero WPS exposure is responsible for the
hyperactive platelet phenotype, including enhanced aggregation, we next determined if the integrin
GPIIb/IIIa (αIIbβ3) activation would also be potentiated. Indeed, our data revealed that activation
of the αIIbβ3 integrin is enhanced in both adult (Figure 2.8A, 2.8B) and in utero WPS exposed
platelets (Figure 2.8C, 2.8D), in contrast with the clean air controls, in response to 0.1 U/mL
thrombin or 5 μM ADP. These results are consistent with the enhanced aggregation shown earlier.

Figure 2.8: Adult and in utero WPS exposure enhance platelet integrin activation. Platelets form adult (A,
B) and in utero (C, D) WPS or clean air exposed platelets were incubated with JON/A antibody, and the
fluorescent intensities were measured by flow cytometry after stimulation with 0.1 U/mL thrombin or 5 μmol/L
ADP. Average mean fluorescence intensities shown (****P < 0.0001; NS. nonsignificant). Each experiment was
repeated 3 times, with blood pooled from at least 8 mice each time.

Adult and in utero WPS Exposure Enhances Phosphatidylserine Expression.
Phosphatidylserine (PS) exposure provides the essential platelet “platform” upon which
the assembly of coagulation factor complexes take place (Hawiger 1987). Therefore, it is important
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to assess any changes in PS expression that may result from WPS exposure. Our data showed that
PS expression was significantly higher in the adult and in utero WPS-exposed platelets, compared
to those from the clean air-exposed mice, upon stimulation with 0.1 U/mL thrombin or 5 μM ADP
(Figure 2.9A, B, C, and D).

Figure 2.9: Platelet phosphatidylserine exposure is enhanced in both adult and in utero WPS exposed mice.
Adult (A, B) and in utero (C, D). Average mean fluorescence intensities shown (****P < 0.0001; NS.
nonsignificant). Each experiment was repeated 3 times, with blood pooled from at least 8 mice each time.

Taken together, our data thus far support the notion that exposure of platelets to WPS, in
adulthood or in utero, produces a hyperactive state, in comparison to clean air. This hyperactive
state (enhanced function) was in the form of enhanced aggregation, secretion, integrin activation,
and phosphatidylserine exposure.
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Adult WPS Exposure Enhances Platelet Spreading.
Platelet spreading is a vital aspect of hemostatic plug formation and thrombosis (Hawiger
1987). To this end, and upon vessel injury, platelet activation mediated via a host of receptorinduced cascades, triggers rapid reorganization of the actin cytoskeleton, thereby resulting in
platelet rounding and adhesion to the surface. Consequently, platelet morphological changes occur,
e.g. filopodia and lamellipodia formation, which ultimately strengthens contact with the surface as
well as to other platelets. As for the impact of adult WPS exposure on spreading, filopodia and
lamellipodia formation is higher/potentiated in the WPS-exposed platelets, compared to those from
the clean air-exposed mice, upon stimulation with 0.1 U/mL thrombin (Figure 2.10). This finding
further supports the notion that WPS results in a hyper-state of platelet activity.

Figure 2.10: Platelet spreading is enhanced in WPS exposed mice. Platelets from adult WPS and clean air
exposed mice were allowed to adhere to fibrinogen‐coated coverslips for 5 minutes after stimulation with
thrombin (0.1 U/mL). (A) Tetramethylrhodamine‐conjugated phalloidin was used to stain for F‐actin and Images
were processed using LAS X Wizard imaging software. (B) Quantification of the spreading data. Data are
representative of 3 independent experiments.
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Adult WPS Exposure and Nicotine Enhance Agonist‐Induced Akt and ERK
Phosphorylation.
A critical signaling mechanism in platelet function and thrombus formation is the
phosphorylation of Akt and/or ERK proteins (Senis et al. 2003, Stojanovic et al. 2006, Garcia et
al. 2005, Woulfe et al. 2004). Therefore, we investigated whether WPS exposure would enhance
phosphorylation of Akt and/or ERK proteins in platelets. Our data showed that Akt and ERK
phosphorylation are enhanced in adult WPS-exposed platelets, relative to controls after stimulation
with 0.1 U/mL thrombin (Figure 2.11A; data quantification is shown in Figure 2.12B). These
results provide biochemical evidence and indicate that Akt and/or ERK are an essential component
in the WPS-mediated modulation of platelets toward a hyperactive state. We next determined
whether nicotine, the WPS chemical, has the capacity to trigger Akt and/or ERK activation.
Indeed, platelets from mice that were injected with nicotine (1 mg/kg IV) exhibited enhancement
of Akt and ERK phosphorylation in response to 5 μM ADP (Figure 2.11C; data quantification is
shown in Figure 2.11D); which is consistent with previous reports (West et al. 2003, Brunzell,
Russell, and Picciotto 2003, Dajas-Bailador, Soliakov, and Wonnacott 2002). This data suggests
that nicotine plays a role “at least in part” in the priming of platelets into a hyperactive state.
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Figure 2.11: Platelet Akt and ERK activation (phosphorylation) are enhanced in adult WPS exposed and
nicotine treated mice. Platelets from WPS and clean air exposed mice as well as from nicotine and vehicle
injected mice were prepared and washed. Platelets were stimulated with 0.1 U/mL thrombin (A) or 5 μmol/L ADP
(C) for 3 minutes, and proteins were lysed using 1X sample buffer. Proteins were separated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis before being subjected to immunoblotting with anti‐Akt, anti‐pAkt
(Ser473), anti‐ERK, and anti‐pERK antibodies. (B. D) Data quantification of agonist-induced ERK and Akt
phosphorylation (****P < 0.0001; ***P < 0.001; NS. nonsignificant). Each experiment was repeated at least 3
times, with blood pooled from a group of 8 mice each time. WPS indicates Waterpipe Smoke.

Adult WPS Exposure Does Not Modulate Plasma Fibrinogen Levels.
To determine if the coagulation system is impacted by WPS, we sought to see if there will
be any change in the plasma concentration of fibrinogen. Our results showed that the plasma
concentration of fibrinogen was not affected in WPS exposed mice in comparison to clean air
under the present experimental conditions (Figure 2.12).

Figure 2.12: WPS exposure does
not affect plasma fibrinogen.
Plasma was collected from WPS
and clean air controls before the
levels of fibrinogen were
measured, NS. nonsignificant.
Each experiment was repeated at
least 3 times, with blood pooled
from a group of 8 mice each time
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Cotinine Enhances Platelet Aggregation and Secretion.
Previous studies suggested that cotinine, the main metabolite of nicotine (with a long halflife) can induce thrombus formation (Sastry and Gujrati 1994). Therefore, we sought to investigate
the effect of cotinine on platelet function (aggregation and secretion ex vivo). Our data revealed
that cotinine (1 μM injection for one week) did, in fact, enhance thrombin-induced platelet
aggregation and dense granule secretion, in comparison to the vehicle control (Figure 2.13A &
2.13B). These data indicate that cotinine is a likely key contributor to WPS’s “negative” effects
on platelets.

Figure 2.13: Cotinine enhances platelet aggregation and dense granule secretion. Mice were injected with 1
μM cotinine or vehicle, once daily for 1 week before platelets were harvested, and stimulated with thrombin (0.1
U/mL), and aggregation (A) and ATP release (B) were monitored using Lumi-aggregometer. The experiment was
repeated 3 times, with blood pooled from at least 8 mice each time.

Adult WPS Exposure Does Not Modulate Expression of Integrin αIIbβ3, PAR4, or PI3K.
We next sought to investigate if the aforementioned effects of WPS may involve changes
in the expression levels of certain platelet proteins, namely integrin αIIbβ3 (GPIIb/IIIa), PAR4,
and PI3K/p85. To this end, we did not observe any detectable changes in the expression levels of
integrin αIIbβ3, PAR4 or PI3K/p85, between WPS and clean air platelets (Figure 2.14A; data
quantification is shown in Figure 2.14B). These data suggest that, at least under the current
experimental conditions, short-term exposure to WPS does not alter the expression of platelet
proteins.
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Figure 2.14: WPS exposure does not modulate the expression of platelets protein. Platelets from WPS and
clean air–exposed mice were prepared and washed. Proteins were lysed using 1× sample buffer, and separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis before being subjected to immunoblotting with antiGPIIb-IIIa (αIIbβ3), anti-PAR4, or anti-p85/PI3K antibodies; (E) data quantification of GPIIb-IIIa, PAR4, and
p85/PI3K expression; NS, nonsignificant. Each experiment was repeated at least 3×, with blood pooled from a
group of 8 mice each time.

Discussion & Conclusion
In this study, we investigated the effect of adult as well as in utero exposure to
hookah/waterpipe smoke (WPS) on platelet function, hemostasis, and thrombogenesis. Similar to
cigarette smoking, our results indicate that exposed mice are under increased risk for thrombosis
with a shortened time for physiological hemostasis, which seems to derive from a hyperactive
platelet function phenotype.
Many studies have undisputedly established that cigarette smoking is a risk factor for
cardiovascular disease, including unstable angina (Daly et al. 1983, Merry et al. 2011), myocardial
infarction (Critchley and Capewell 2003), and stroke (Shinton and Beevers 1989). On the other
hand, despite its widespread use and being a rising trend in the west (Jukema, Bagnasco, and
Jukema 2014b, Jawad et al. 2018, Salloum et al. 2017, Primack et al. 2015, Orth and Merkel 2018)driven by its perceived “less harm”- studies on the effects of waterpipe smoking/WPS on
cardiovascular disease are limited. Moreover, the direct consequences of WPS exposure in the
context of platelets and thrombosis are yet to be investigated. Waterpipes carry a toxic profile that
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is thought to be comparable or to even exceed that of cigarette smoking (Khabour, Alzoubi, et al.
2012b, Sepetdjian, Shihadeh, and Saliba 2008a, Sepetdjian et al. 2013, Primack et al. 2016), which
would suggest that they have “similar” negative health effects. In fact, according to some studies,
the smoke emitted from a single waterpipe tobacco smoking episode contains eight times the CO,
three times the nitric oxides, an average of 11.5 times the acrolein, an average of 18.2 times the
formaldehyde, and up to 245 times the Polycyclic aromatic hydrocarbons (PAHs)(Shihadeh 2003b,
Shihadeh and Saleh 2005, Al Rashidi, Shihadeh, and Saliba 2008, Primack et al. 2016), relative to
a single regular tobacco cigarette.
Based on the aforementioned considerations, and limitation of previous studies, we sought
to “uncover” the effects of direct short term WPS exposure on platelet function in adult mice, and
the effect of WPS exposure on platelet function of offspring mice exposed in utero/during
pregnancy by employing a “novel” whole-body exposure protocol that simulates real-life exposure
scenarios (Shihadeh et al. 2004). An important aspect of our system is the fact that it involves
minimal animal handling, with the animals unrestrained and less stressed. Thus, the animal model
we used in our study (mice) should provide translational results that are clinically applicable to
humans, especially in the context of tobacco exposure (Morissette et al. 2014, Churg and Wright
2007), especially since the number of puffs, puff interval, etc., are based on human exposure data.
Of note, this model gives us flexibility in mimicking many aspects of human exposure that cannot
be directly obtained from human, due to ethical considerations and other challenges (Moolchan
and Mermelstein 2002).
Therefore, the primary aim of this project was to determine the effects of 1) short-term
WPS exposure on adult platelet function, hemostasis and thrombosis; and that of 2) in utero WPS
exposure on platelet activation, and the genesis of thrombosis. Our findings revealed- for the first
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time- that short term exposure to WPS in adult mice and in utero significantly reduced the bleeding
time in exposed mice, and increased their tendency to carotid artery thrombosis. These findings
provide evidence that WPS is not safe as the common misperception implies, even with a shortterm exposure of only seven/7 days, and that its harmful effects are transmitted to the offspring
when exposure takes place in utero. In addition, our data are consistent with other reports that
short-term use of waterpipes disrupts normal cardiovascular function (Hakim et al. , Shaikh et al.
2008, Kadhum et al. 2014, Azar et al. 2016, Al-Kubati et al. 2006, Eissenberg and Shihadeh 2009,
Hawari et al. 2013, Layoun et al. 2014), and that exposure to other forms of tobacco impacts
hemostasis and thrombosis (Karim, Alshbool, et al. 2015, Sithu et al. 2010a). Notably, patients
who have a history of cardiovascular disease (e.g. atherosclerotic disease) are probably at a higher
risk of having negative outcomes from waterpipe use, and this is might be because the
atherosclerotic vessels are more prone to thrombotic events than normal vessels.
We next investigated the mechanism by which enhanced hemostasis and thrombosis may
have manifested in the adult WPS as well as in utero exposed mice. Importantly, since it has been
shown that an increase in platelet activity plays a major role in the pathogenesis of acute
myocardial infarction (MI)(Tousoulis et al. 2010) and acute stroke (Mulley et al. 1983, Cevik et
al. 2013, McCabe et al. 2004) and since thrombosis is the main mechanism of smoking-related
cardiovascular mortality (Barua and Ambrose 2013), this notion was investigated herein. Our
results demonstrated that agonist‐induced platelet aggregation, secretion (dense and α granules),
integrin activation, phosphatidylserine expression, are all enhanced in both adult as well as in utero
WPS exposed platelets. Furthermore, platelet spreading was enhanced as a result of adult WPS
exposure. Moreover, a similar enhancement of platelet aggregation and dense granule secretion
was observed when adult mice were exposed to a different waterpipe/hookah tobacco brand (see
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Methods for details). It is noteworthy that one study in humans reported a significant increase in
TXB2 levels - a metabolite of the biologically active TXA2- after a single waterpipe smoking
session (Wolfram et al. 2003). This increase in TXB2 levels would suggest an increase in platelet
activity (Catella et al. 1986), which is consistent with our findings. Together, these findings
support our initial hypothesis that WPS exposure (similar to cigarette smoking) modulates platelets
to a state of hyperactivity, which eventually leads to the prothrombotic phenotype observed in the
short-term WPS exposed adult as well as in utero WPS-exposed mice. Notably, there were no
changes in platelet count under our adult exposure protocol. This indicates that direct short-term
(7 days) exposure to WPS does not result in any change in platelet formation. This data is
consistent with a report that showed an insignificant difference in platelet count in mice exposed
to waterpipe smoke (Nemmar et al. 2013). Furthermore, similar to the adult studies, our results did
not show any change in the platelet count in the in utero exposed offspring even though the in
utero exposure lasted throughout the 21 days of gestation. However, whether platelet number
would change if adult waterpipe exposure is repeated over longer periods of time (months), as was
reported previously with waterpipe exposure (Nemmar, Al-Salam, Yuvaraju, et al. 2017), or is
extended beyond the gestation period remains to be determined.
Given the “functional” evidence we have obtained thus far, we next examined whether
platelet activation-mediated downstream signaling, namely Akt and ERK activation, would also
be impacted by WPS exposure in adult mice. Our data showed an increase in the levels of
phosphorylated Akt and ERK in the WPS exposed platelets in comparison to the clean air controls.
Interestingly, we previously observed similar results with exposure to e-cigarette (Qasim et al.
2018). This might suggest an overlap between waterpipes and e-cigarettes with regard to the
mechanism by which they enhance platelet activation, which is presumably through nicotine. The
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latter notion is consistent with previous findings that nicotine upregulates Akt and ERK pathways
(West et al. 2003, Dajas-Bailador, Soliakov, and Wonnacott 2002, Brunzell, Russell, and Picciotto
2003), a notion we were able to verify under our experimental conditions, i.e., platelets from
nicotine treated mice showed an increase in phosphorylation of Akt and ERK. Given the short
half-life of nicotine (6-7 minutes), one cannot exclude the fact that one of its metabolites could be
responsible for the enhanced Akt and ERK activation.
As far as what toxic ingredient(s) in waterpipe smoke that might be responsible for the
hyperactive state of platelets, several toxicants have been found including nicotine/cotinine
(Shihadeh and Saleh 2005, Schubert et al. 2011, Shihadeh 2003b, Jacob et al. 2011, Shihadeh et
al. 2012), aldehydes (Shihadeh et al. 2012, Al Rashidi, Shihadeh, and Saliba 2008), particulate
matter (Monn et al. 2007) as well as furanic and phenolic compounds (Sepetdjian et al. 2013,
Schubert et al. 2012). To this end, we found that treatment with cotinine- one of nicotine’s main
metabolites- is capable of priming platelets into a hyperactive state. These data support the notion
that cotinine is a key toxic waterpipe ingredient, and is a likely contributor to their prothrombotic
phenotype, as well as to their harmful effects on the cardiovascular system. It is noteworthy that
the amounts of these toxicants vary between waterpipe compared with cigarette smoke (per
cigarette/ and per pack/day) due to different heating process and charcoal combustion (Chaouachi
2009, Shihadeh et al. 2014, Calafat et al. 2004, Moldoveanu, Coleman, and Wilkins 2008).
Although the effect of each one of these chemicals on platelets is not fully studied, particulate
matter (Mutlu et al. 2007, Wilson et al. 2010) and the aldehyde acrolein (Sithu et al. 2010a) were
indeed found to enhance platelet function. Of note, waterpipes may, in fact, result in higher levels
of nicotine given the longer duration of a session, and which involves 100-200 times the volume
of smoke from a single cigarette. This also applies to other toxins in tobacco (Cobb et al. 2010).

58

Regarding carbon monoxide (CO), which is one of the main toxic ingredients of WPS, there is a
debate regarding its impact on hemostasis and platelet function. On the one hand, studies reported
an inhibitory effect on hemostasis and platelet function, whereas on the other hand, other studies
reported an enhancing effect on hemostasis and platelet function (Nielsen and Pretorius 2014).
This controversy may be related to the variability in the exposure protocols, as well as the methods
used. Nonetheless, CO may have contributed to the negative health effects we observed with WPS.
We also examined whether the adult WPS phenotype observed may involve modulation of
coagulation, or changes in the basal expression of receptors and/or signaling molecules/proteins
critically involved in platelet activation. Our data showed no detectable differences in the plasma
levels of the clotting factor fibrinogen between the WPS and control mice. In terms of changes in
the basal expression levels of proteins, our data revealed that there was no difference in the levels
of the integrin αIIbβ3, PAR4 and p85 (PI3K) proteins between the control and the WPS platelets.
However, one cannot exclude the possibility that other aspects of coagulation and/or that the
expression of other proteins may have changed. It is also possible that different real-life exposure
scenarios may lead to changes in the plasma levels of fibrinogen and/or the expression levels of
platelet proteins. Of note, higher fibrinogen plasma levels were reported in long term waterpipe
smokers (Seyyed Hashem Sezavar 2004), and it was previously shown that the levels of the P2Y12
receptor protein do change in megakaryoblasts and other cells (Shanker et al. 2006), in response
to nicotine.
Notably, it is well documented that regular cigarette smoking and (more recently) ecigarettes enhance platelet function and increase the risk of thrombosis (Davis et al. 1985, Qasim
et al. 2018), and our present studies show “similar” negative effects from WPS. However,
comparative studies regarding differences in the magnitude or potency of each form of tobacco are
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lacking but clearly warranted to better understand and appreciate the relative risk associated with
each form.
The present study did not address the role of sex in the negative health consequences of
waterpipe, as it employed exclusively male mice to minimize the variability that would be caused
by hormonal fluctuations associated with the female’s reproductive cycle (Fields 2014). Moreover,
it is highly likely that “non-platelet” factors are contributing to the prothrombotic phenotype
associated with WPS/hookah. These issues will be the subject of future investigations.
In summary, by employing a validated animal exposure model, we are the first to
investigate the impact of whole‐body WPS/waterpipe exposure on platelet function, homeostasis,
and thrombosis. Furthermore, we are first to report that in utero WPS exposure can impact
hemostasis and increase the risk of thrombosis in adult offspring. In conclusion, our findings
provide evidence to argue against the common/currently held beliefs regarding the perceived
safety of waterpipe smoking, which is expected to raise awareness regarding the negative health
consequences of this increasingly popular form of tobacco.

60

Chapter III: The Impact of Inhibition of Gβγ Subunits on Hemostasis and Thrombogenesis

Introduction
Platelets are anucleated cells responsible for maintaining hemostasis in the cardiovascular
system through the formation of primary hemostatic plugs (Vilahur et al. 2018), which is a highly
regulated process. In contrast, unbalanced platelet activation contributes to the initiation of
thrombus formation in numerous ischemic medical conditions, such as unstable angina,
myocardial infarction, and stroke (Furie and Furie 2008). Thus, there is a thin line between the
state of physiological hemostasis and pathological thrombosis, with this “tiny” difference
maintained by a network of diverse membrane receptors that operate under strict conditions.
Platelet membrane receptors are the point of contact between platelets and their external
environment through a wide range of agonists including thrombin, thromboxane A2, and ADP
(Amelirad et al. 2019, Kunapuli and Daniel 1998). Platelet receptors play a direct role in platelet
function, either through platelet activation, adhesion with damaged endothelial cell walls, or with
other platelets to form a thrombus (Amelirad et al. 2019). G-protein coupled receptors (GPCRs)
are among the main receptors that have a critical role for platelet function (Offermanns 2006).
Activation of GPCRs by it agonists (thrombin, thromboxane A2, and ADP), causes the replacement
of the GDP by GTP on α subunit of the heterotrimeric Gαβγ complex (Gilman 1987), facilitating
conformational changes of α subunit and exposing sites on both Gα and Gβγ for interactions with
downstream effectors (Smrcka 2008). Much is known about Gα and its critical role on platelet
function (Jin, Daniel, and Kunapuli 1998, Daniel et al. 1998, Hollopeter et al. 2001, Foster et al.
2001, Djellas et al. 1999, Offermanns 2001). On the contrary, less is known about the Gβγ subunits
in platelets and their contributions to platelet function.
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In humans, 5 Gβ and 12Gγ subunits have been described (Hurowitz et al. 2000), a variety
that in theory can make up to 60 combinations of Gβγ dimer. However, in reality, not all these
combinations exist, expressed, or can dimerize (Yim et al. 2019). Early investigations showed that
Gβγ subunits function was only restricted to the negative regulation of α subunit of the
heterotrimeric Gαβγ complex (Lau et al. 2013). However, further studies revealed that Gβγ
regulate important effectors such as adenylate cyclase (AC), G protein-coupled receptor kinase 2
(GRK2)(Pitcher et al. 1992), phospholipase Cβ1, β2 and β3 isoforms (Camps et al. 1992, Park et
al. 1993, Smrcka and Sternweis 1993), inward rectifying potassium channels (GIRK)(Logothetis
et al. 1987, Nakajima, Nakajima, and Kozasa 1996), N-type calcium channels (Ikeda 1996), and
most importantly phosphoinositide 3 kinases (PI3K) (Stephens et al. 1994, Stephens et al.
1997),(Guillermet-Guibert et al. 2008). It is noteworthy that in platelets, PI3K is an important
effector downstream of P2Y12 and regulates αIIbβ3 activity, which is essential for thrombus
formation (Cosemans et al. 2006). To this end, the Gβγ subunits have been suggested as an effector
for PI3K in platelets downstream of ADP/P2Y12, mostly through a “guilt by association” approach
(Kim and Kunapuli 2011), but their role was not investigated first hand.
A number of studies suggested that pharmacological targeting of Gβγ subunits can serve
as a modulator of some disease-related pathological conditions. For instance, inhibiting Gβγ
subunits slowed the development of inflammation (Hirsch et al. 2000, Li et al. 2000), prevented
the development of cardiomyopathy and heart failure in mice (Koch et al. 1995, Rockman et al.
1998), negatively modulate opioid responses (Xie et al. 1999), attenuated addiction (Yao et al.
2003), and inhibited tumor metastasis (Bookout et al. 2003). In platelets, while inhibiting GPCRs
is considered one of the most common therapeutic approaches to prevent thrombosis (Gurbel,
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Kuliopulos, and Tantry 2015), whether similar therapeutic value can be achieved by inhibiting
Gβγ subunits in platelets is the concern of this study.
Therefore, we investigated the role of Gβγ subunits in platelet function, hemostasis, and
thrombosis using small molecule inhibitor, namely gallein. We found that inhibiting Gβγ subunits
in platelets in vitro results in reduced platelet aggregation, secretion, integrin activation, as well as
clot retraction and platelet spreading. Further, this inhibition in platelet function was translated in
vivo to a prolonged tail bleeding time and increased occlusion time in a FeCl3-induced injury model
of thrombus formation. Together, our findings support the hypothesis that inhibiting Gβγ subunits
modulates platelet function, hemostasis, and thrombogenesis.
Methods
Reagents and Materials
Gallein and DMSO were from Tocris Bioscience (Minneapolis, MN). ADP and collagen
were from Chronolog Corporation (Havertown, PA), whereas PGI2 was from Cayman Chemical
(Ann Arbor, MI). Fibrinogen and apyrase were from Sigma Aldrich (St. Louis, MO). Microscope
slides were from Fisher Scientific (Hanover Park, IL). Coverslips were from Neuvitro Corporation
(Vancouver, WA). CD62P, Annexin V, and PAC-1 FITC antibodies were from BD Biosciences
(San Jose, CA). All other reagents were of analytical grade.
Animals
C57BL/6 J mice were from Jackson Laboratories (Bar Harbor, ME). All mice used for
experiments were 8–10 weeks of age, and housed in groups of 1–4 at 24 °C, under 12/12 light/dark
cycles, with access to water and food ad libitum. All experiments involving animals were
performed in compliance with the relevant laws and institutional guidelines and approved by the
Institutional Animal Care and Use Committee of The University of Texas at El Paso.
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Human Subjects
The Institutional Review Board approved human blood studies, and donors were asked to
sign a written consent.
Platelet‐Rich Plasma Preparation
We prepared platelets as previously described (Karim et al. 2016). Blood was collected
from human volunteers through a venous puncture. Blood was also collected from mice through
heart puncture. Coagulation was inhibited by 0.38% sodium citrate solution (Fisher Scientific).
Blood was centrifuged (237g for 15 minutes) at room temperature (RT), and the platelet‐rich
plasma was then collected. Platelets were counted with the HEMAVET 950FS Multispecies
Hematology System, and the counts were adjusted to 7×107 platelets per mL before each
experiment.
Washed Platelet Preparation
Blood was collected as discussed above. Platelet‐rich plasma (PRP) was recovered and
platelets were pelleted at 483g for 10 minutes at RT. The pellets were resuspended in
HEPES/Tyrode buffer (20 mmol/L HEPES/potassium hydroxide, pH 6.5, 128 mmol/L NaCl,
2.8 mmol/L KCl, 1 mmol/L MgCl2, 0.4 mmol/L NaH2PO4, 12 mmol/L NaHCO3, 5 mmol/L d‐
glucose) supplemented with 1 mmol/L EGTA, 0.37 U/mL apyrase and 10 ng/mL PGI2. Platelets
were then washed and resuspended in HEPES/Tyrode (pH 7.4) without EGTA, apyrase, or PGI2.
Platelets were counted using the HEMAVET 950FS Multispecies Hematology System and
adjusted to the indicated concentrations.
In vitro Platelet Aggregation
PRP from human blood samples was incubated with vehicle (DMSO) or 25-100 M
gallein for 5 min. The samples were then stimulated with 1 μmol/L ADP, or 5 μg/mL
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collagen. Platelet aggregation was measured using the turbidometric method, with a model 700
aggregometry system (Chronolog Corporation, Havertown, PA).
Flow Cytometric Analysis
Flow cytometric analysis for P-selectin, Annexin-V or PAC1 was performed as we
described before (Lin et al. 2014). Shortly, human washed platelets were incubated either with
vehicle or gallein (50 M) for 5 min and then stimulated with ADP 10 μmol/L or collagen 5 μg/mL
for 3 min. Platelets were then incubated with FITC-conjugated anti–P-selectin to measure αgranule secretion, FITC-conjugated anti-Annexin V to measure phosphatidylserine exposure, or
PAC-1 antibodies to measure GPIIb-IIIa activation. Finally, fluorescent intensities were measured
using a BD Accuri C6 flow cytometer and analyzed using compatible software CFlow Plus (BD
Biosciences, Franklin Lakes, NJ).
Fibrin Clot Retraction Assay
Clot retraction assay was performed as previously described (Vemana et al. 2015). Briefly,
whole blood was collected and washed platelets were isolated as discussed above. CaCl2 was
added extemporaneously, at a final concentration of 1 mmol/L. The glass tubes that were used for
aggregation (Chrono‐Log Corporation) were employed for retraction assays. The washed platelets
were resuspended at 1×108/mL in HEPES‐Tyrode buffer (pH 7.4). Fibrinogen (500 μg/mL) was
added in 0.5‐mL platelets aliquots, and clot retraction was initiated by quickly adding thrombin
(0.1 U/mL). The reaction was transferred to the glass tube and the reaction was set at RT. Pictures
were taken at time intervals of 5 minutes up to 35 minutes using a digital camera. Comparison is
based on the difference in clot size
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Spreading Assay
Immunofluorescence microscopy was used to assess platelet spreading, as previously
described (Choi, Karim, and Whiteheart 2006). In brief, washed platelets were allowed to incubate
in the presence or absence of gallein (50 M) for 5 min. Then, they were left as is (resting) or
treated with 10 μmol/L ADP for 5 min at 37 °C and placed onto fibrinogen-coated coverslips for
30 min. Platelets were fixed, rinsed/washed and incubated with either FITC/TRITC-conjugated
phalloidin. The coverslips were examined and imaged using a Leica DMi8 inverted widefield
fluorescence microscope with integrated high‐precision focus drive. Images were processed using
LAS X Wizard imaging software. Objective lenses used were a ×63/×100 numeric aperture. Type
A immersion oil (Fryer) was used for the ×63 objective. Comparison is based on the difference in
level of spreading.
Tail Bleeding Time
Mice were IV injected with either gallein (20 mg/kg/twice per day) or vehicle and the tail
bleeding assay was performed after 1 h, as described before (Lin et al. 2014). Briefly, mice were
anesthetized before the tail was transected at a distance of 5 mm from the tip. The tail was then
immediately immersed in saline maintained at 37 °C at a constant temperature, and the time to
bleeding cessation was measured (observed visually).
In Vivo Thrombosis
Mice were IV injected with either gallein (20 mg/kg/twice per day) or DMSO and the
FeCl3-induced thrombosis model was performed after 1 hour, as described before (Lin et al. 2014).
An hour post injection, animals were anesthetized, and a midline incision of the skin was made
and a segment of the left common carotid artery was exposed and cleaned. Baseline carotid blood
flow was measured and recorded before thrombosis was caused by placing a filter paper
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(0.5 × 1 mm) saturated with 7.5% ferric chloride, onto the carotid artery. The carotid blood flow
was continuously monitored for 45 min after ferric chloride application, and the data was
registered by a computerized data acquisition program (LabChart6, ADInstruments, Colorado
Springs, CO). Time to occlusion was calculated as the difference in time between the removal of
the filter paper and stable occlusion.
Statistical Analysis
All experiments were performed at least three times with blood from three different human
donors or in case of mouse platelets, pooled from three groups of eight-ten mice. Analysis of the
data was performed using GraphPad PRISM statistical software (San Diego, CA) and presented as
mean ± SEM. The Mann-Whitney test was used for the evaluation of differences in mean
occlusion and bleeding times, whereas the t-test was used for FACS data analysis. Significance
was accepted at P < 0.05 unless stated otherwise.
Results
In Vitro Inhibition of Gβγ Subunits Reduces Platelet Aggregation
To understand the role of Gβγ in platelet function, we sought to examine the impact of
inhibiting Gβγ subunits on platelet aggregation. Therefore, we employed light transmittance
aggregometry, and human platelets were incubated with either gallein (25 μM) or DMSO (used as
a vehicle “control”) for 5 min before activation with ADP. Our initial observation revealed that
platelets incubated with gallein showed reduced ADP-induced platelet aggregation when
compared to vehicle (Figure 3.1A). This inhibition was found to be dose-dependent as 50 μM of
gallein produced further inhibition of ADP induced platelet aggregation. Surprisingly, collageninduced aggregation was also inhibited in platelets incubated with gallein (50 μM), when compared
with vehicle (Figure 3.1B). Collagen/GPVI-mediated platelet activation (non-GPCR) is thought to
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involve feedback pathways such as ADP, which in turn can act in an autocrine/ paracrine manner
on their cognate GPCRs to amplify aggregation and secretion.

Figure 3.1: Platelet aggregation is inhibited by gallein. Platelets from gallein and vehicle treated mice were
stimulated with 1 μmol/L ADP (A), or 5 μg/ml collagen (B), before their aggregation responses were measured.
The experiment was repeated 3 times, with blood pooled from at least 8 mice each time.

Inhibition of Gβγ Subunits Reduces Platelet Secretion.
Platelet secretion plays an important role in amplifying platelets' initial response. Thus, we
sought to investigate the impact of Gβγ on platelet secretion. As was the case with aggregation,
ADP-induced dense granule secretion was inhibited in human platelets incubated with gallein (25
M) in comparison to vehicle. This inhibition was dose-dependent as 50 μM of gallein further
lowered the secretion induced by ADP (Figure 3.2A). Similarly, we observed inhibition in αgranule secretion (P-selectin; Figure 3.2C). We also found that collagen-induced platelet dense
granule (Figure 3.2B), as well as α-granule secretion (Figure 3.2D), is inhibited when human
platelets are incubated with gallein (50 μM) in comparison to vehicle.
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Figure 3.2: Gallein inhibits platelet dense and alpha granules release. (A, B) Dense granule secretion
responses were measured in a lumi-aggregometer. Platelets were incubated with luciferase (12.5 μL) for the dense
granules measurements. (C, D) Alpha granule secretion was measured by incubating platelets with P-selectin (for
α granules), and the fluorescent intensities were measured by flow cytometry after stimulation with 5 μmol/L
ADP or 5μg/mL collagen. The experiment was repeated 3 times, with blood pooled from at least 8 mice each
time.

Overall, these results indicate that inhibiting Gβγ subunits has the capacity to suppress
ADP- induced platelet aggregation/secretion. These results support our initial hypothesis that Gβγ
subunits play an important role in platelet activity given the fact that Gβγ subunits convey signals
downstream GPCRs; and the latter are known to play a central role in platelet function. To our
surprise, inhibition of Gβγ led to inhibition of in collagen-induced platelet aggregation, which
suggests a cross-talk between GPCRs and collagen receptors (Roger et al. 2004), or that Gβγ plays
a non-canonical role in platelet activation.
Inhibition of Gβγ Subunits Reduces Platelet Integrin Activation
Integrin is a cell adhesion receptor that plays an important role in cell adhesion
(aggregation), spreading, retraction, as well as the process of thrombosis (Estevez, Shen, and Du
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2015, Karim, Vemana, et al. 2015). Therefore, we next investigated whether inhibition of Gβγ
would be associated with a commensurate inhibition of αIIbβ3 activation. Indeed, our data
revealed that inhibition of Gβγ inhibits αIIbβ3 integrin activation in platelets treated with gallein
in comparison to vehicle. (Figure 3.3A) in response to 5 μmol/L ADP and 5 μg/mL collagen. These
results are consistent with the inhibition of aggregation response in gallein treated platelets we
observed.

Figure 3.3: Gallein inhibits αIIbβ3 activation in platelets. Platelets form healthy human participant treated with
gallein or vehicle were incubated with PAC1 antibody, and the fluorescent intensities were measured by flow
cytometry after stimulation with 5 μmol/L ADP or 5 μg/ml collagen. Average mean fluorescence intensities shown
(**P < 0.01; NS. nonsignificant). The experiment was repeated 3 times, with blood pooled from at least 8 mice
each time.
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Inhibition of Gβγ Subunits Alters Hemostasis and Inhibits Thrombosis
Under our in vitro experimental setting, we established that inhibiting Gβγ subunits with
small molecular inhibitor gallein significantly inhibits platelet functional responses. Next, we
sought to assess if inhibition of Gβγ subunits exerts any effects in vivo. Thus, we injected C57BL/6
J mice with small molecular inhibitor (gallein 20 mg/kg twice/day for 3 days). Next, we assessed
the impact of inhibition of Gβγ subunits on thrombogenesis, using FeCl3-induced carotid artery
thrombosis model, and on hemostasis, a using tail bleeding time assay. We found that mice injected
with gallein (20 mg/kg twice/day for 3 days) had a significantly increased occlusion time. In fact,
while complete occlusion of the vessel was found to occur shortly after FeCl3 treatment in the
control, it was significantly delayed in the gallein injected mice (Figure 3.4A). Similarly, a
prolonged tail bleeding time was observed in gallein injected mice, relative to controls (Figure 3.4
B). Taken together, the above data provide evidence- for the first time- that inhibition of the Gβγ
subunits not only exerts anti-thrombotic effects, but it also impacts physiological hemostasis.

Figure 3.4: Gallein treated mice exhibit prolonged occlusion and bleeding times. (A) This data illustrates the
results of the ferric chloride–induced thrombosis model (as described in the “Methods”) comparing gallein and
vehicle treated mice time to occlusion. Each point represents the occlusion time of a single animal (DMSO, n=5;
and gallein, n=5; **P<0.01). (B) This data illustrates the results of tail bleeding time assay (as described in the
“Methods”) comparing gallein and vehicle treated mice. Each point represents the tail bleeding time of a single
animal (DMSO, n=5; and gallein, n=5; *P<0.05).
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Inhibiting Gβγ Subunits Impairs Clot Retraction and Inhibits Platelet Spreading
Activation of integrin αIIbβ3 is required for clot retraction and platelet spreading through
“outside-in signaling” that triggers an internal signaling cascade. Whether Gβγ subunits play a role
in integrin αIIbβ3 signaling cascade is not yet determined. Thus, we sought to investigate Gβγ
subunits' role in clot retraction and platelet spreading. Our data shows a defect in clot retraction as
well as platelet spreading after inhibition of Gβγ subunits by small molecular inhibitor gallein
(Figure 3.5 A, 5B). These data indicate that the Gβγ subunits participate in “outside-in signaling”
of platelet.

Figure 3.5: Gallein treatment inhibits clot retraction and platelet spreading. (A) Whole blood was collected
from both gallein and vehicle treated platelets and washed platelets were isolated as discussed in
the Methods section. Clot retraction was initiated by adding thrombin (0.1 U/mL) and photographed every
5 minutes for 35 minutes. (B) Platelets from gallein and vehicle–treated platelets were allowed to adhere to
fibrinogen-coated coverslips for 5 min after stimulation with thrombin (0.1 U/mL). TRITC Phalloidin and FITC
phalloidin were used to stain for F-actin and imaged using Leica DMi8 inverted widefield fluorescence
microscope with integrated high precision focus drive. Images were processed using LAS X Wizard imaging
software. G: Gallein.

Discussion & Conclusion
Herein we show data- some of which for the first time- that inhibiting Gβγ subunits using
a small molecular inhibitor- inhibits platelet function in vitro as well as alters hemostasis and
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inhibits thrombosis in vivo. The Gβγ subunits are central players in intracellular signal transduction
after GPCRs activation (Smrcka 2013), which make it a viable pharmacological target, especially
because GPCRs are the most extensively studied drug targets (Overington, Al-Lazikani, and
Hopkins 2006), and their involvement in human diseases is well-known (Hauser et al. 2017). Our
results show that inhibiting Gβγ subunits leads to inhibition of agonist- (e.g., ADP-) induced
platelet aggregation as well as dense granule secretion. ADP is an important platelet agonist that
operates through two GPCRs (P2Y1, P2Y12) (Cattaneo et al. 1990, Hollopeter et al. 2001,
Cattaneo and Gachet 1999). ADP receptors are critical for platelet aggregation, thromboxane A2
generation, procoagulant activity, adhesion to immobilized fibrinogen and thrombus formation
under shear conditions (Murugappa and Kunapuli 2006).
Advances in studying ADP receptors resulted in the development of drugs like clopidogrel
and ticlopidine, which although extensively used in clinical settings, carry many serious side
effects (Quinn and Fitzgerald 1999). Targeting Gβγ subunits of the ADP receptors provide more
specificity and selectivity in inhibiting platelets activity; this is in part because small molecule
inhibitors would not (necessarily) block all GPCR functions. For instance, Gβγ inhibitors do not
block activation of Gα subunits by GPCRs, further; Gβγ small molecular inhibitors only block a
subset of downstream targets, leaving other process intact (Smrcka 2013). On the contrary, the
most commonly used ADP receptor inhibitors cause a complete block of all processes downstream
of GPCRs, and in many cases lead to irreversible inhibition (Coukell and Markham 1997, Mills et
al. 1992). To this end, these features of inhibiting Gβγ subunits illustrate a new approach to
inhibiting platelets with more specificity. To our surprise, targeting Gβγ subunits led to inhibition
of collagen-induced platelet aggregation and dense granule secretion. These results might allude
to a role for Gβγ subunits in the cross-talk between collagen receptors and GPCRs. Indeed, it has
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been long recognized that agonists such as ADP and thromboxane A2 are involved in collageninduced platelet aggregation to amplify its response (Ardlie, Garrett, and Bell 1986). Moreover,
the Gβγ subunits may also play a vital non-canonical role in platelet function, similar to what we
have reported with the regulator of G-protein signaling (RGS) proteins (Hernandez et al. 2019,
Alshbool et al. 2015, Hensch et al. 2016). The aforementioned effect seen in aggregation and
secretion did correspond to reduced activation of integrin αIIbβ3 in platelets treated with gallein.
Integrin αIIbβ3 is a major player in platelet function.
To better understand the role of Gβγ subunits in platelets, we sought to investigate whether
the effects we observed in vitro would be translated to alteration in hemostasis and thrombosis
when the platelets are in their natural milieu (in vivo). Our results demonstrated and for the first
time that inhibiting Gβγ subunits modulates hemostasis _ increases tail bleeding time _ and inhibits
arterial thrombus formation_ increases time to occlusion. These findings are consistent with the
observed in vitro phenotype and support the initial hypothesis that the Gβγ subunits do indeed
serve as modulators of platelet function, hemostasis, and thrombogenesis.
After being activated, platelets transform and flatten themselves to increase their surface
contact area at the site of a vascular injury by maneuvering their plasma membrane. This process
is called platelet spreading and involves outside-in signaling of αIIbβ3(Lee et al. 2012). This shape
change or spreading of activated platelets is an essential step for normal hemostasis, as well as
thrombogenesis (Furie and Furie 2008). Our findings show that in the presence of the Gβγ subunits
inhibitor, platelet spreading was dramatically reduced. In the same context, we also observed
inhibition of clot retraction in platelets treated with the Gβγ subunits inhibitor. These findings
suggest that Gβγ subunits play a role in outside-in-signaling of integrin αIIbβ3. To this end, studies
have shown that Gβγ subunits regulate small G-proteins such as Rho and Rac that have impact on
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platelet shape change and clot retraction (Chari-Turaga and Naik 2011, Cervantes-Villagrana et al.
2019).
In summary, our results provide evidence that pharmacological inhibition/targeting of Gβγ
subunits reduces platelet function, both in vitro and in vivo. Consequently, Gβγ subunits have the
potential to serve as a target to develop a therapeutic agent that can be added to the available
interventions to manage thrombotic disorders. Targeting Gβγ subunits might be advantageous
because it is potentially more selective(Smrcka 2013) compared to antiplatelet agents that target
GPCRs. Future studies are warranted to investigate these notions.
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Glossary

ADP

Adenosine diphosphate

AKT

Protein kinase B

BDNF

Brain-derived neutrophic factor

BP

Blood pressure

CVD

Cardiovascular disease

CAD

Coronary artery disease

CEA

Carcinoembryonic antigen

CO

Carbon monoxide

DNA

Deoxyribonucleic acid

ENDS

Electronic nicotine delivery systems

ERK

Extracellular signal regulated kinases

EPA

Environmental Protection Agency

FDA

Food and Drug Administration

FEF

Forced expiratory flow

FeNO

Fractional exhaled nitric oxide

FEV

Forced expiratory volume

FMD

Flow-mediated dilation

FVC

Forced vital capacity

GPCRs

G-protein coupled receptors

GSH

Glutathione

HR

Heart rate

HCT

Hematocrit

IHD

Ischemic heart disease

IL

Interleukin

MPV

Mean platelet volume

MI

Myocardial infarction

mRNA

Messenger RNA

NO

Nitric oxide

PS

Phosphatidylserine

PAHs

Polycyclic aromatic hydrocarbons

RNA

Ribonucleic acid

ROS

Reactive oxygen species

TXB2

Thromboxane B2

TNF

Tumor necrosis factor

WPS

Waterpipe smoke

VEGF

Vascular endothelium growth factor
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